FLOTEK INDUSTRIES INC/CN 0000928054 12/31 2023 Q3 FALSE http://flotekind.com/20230930#DebtInstrumentRealizedGainLossOnFairValueAdjustmentBeforeTax http://flotekind.com/20230930#DebtInstrumentRealizedGainLossOnFairValueAdjustmentBeforeTax 0.1667 0000928054 2023-01-01 2023-09-30 0000928054 2023-11-07 xbrli:shares 0000928054 2023-09-30 iso4217:USD 0000928054 2022-12-31 0000928054 us-gaap:NonrelatedPartyMember 2023-09-30 0000928054 us-gaap:NonrelatedPartyMember 2022-12-31 0000928054 us-gaap:RelatedPartyMember 2022-12-31 0000928054 us-gaap:RelatedPartyMember 2023-09-30 iso4217:USD xbrli:shares 0000928054 us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0000928054 2023-07-01 2023-09-30 0000928054 2022-07-01 2022-09-30 0000928054 2022-01-01 2022-09-30 0000928054 2021-12-31 0000928054 2022-09-30 0000928054 us-gaap:CommonStockMember 2023-06-30 0000928054 us-gaap:TreasuryStockCommonMember 2023-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000928054 us-gaap:RetainedEarningsMember 2023-06-30 0000928054 2023-06-30 0000928054 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000928054 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000928054 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000928054 us-gaap:CommonStockMember 2023-09-30 0000928054 us-gaap:TreasuryStockCommonMember 2023-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000928054 us-gaap:RetainedEarningsMember 2023-09-30 0000928054 us-gaap:CommonStockMember 2022-06-30 0000928054 us-gaap:TreasuryStockCommonMember 2022-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000928054 us-gaap:RetainedEarningsMember 2022-06-30 0000928054 2022-06-30 0000928054 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000928054 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000928054 us-gaap:TreasuryStockCommonMember 2022-07-01 2022-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000928054 us-gaap:CommonStockMember 2022-09-30 0000928054 us-gaap:TreasuryStockCommonMember 2022-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000928054 us-gaap:RetainedEarningsMember 2022-09-30 0000928054 us-gaap:CommonStockMember 2022-12-31 0000928054 us-gaap:TreasuryStockCommonMember 2022-12-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000928054 us-gaap:RetainedEarningsMember 2022-12-31 0000928054 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000928054 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000928054 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember ftk:ProFracAgreementMember 2023-01-01 2023-09-30 0000928054 ftk:ProFracAgreementMember 2023-01-01 2023-09-30 0000928054 us-gaap:CommonStockMember 2021-12-31 0000928054 us-gaap:TreasuryStockCommonMember 2021-12-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000928054 us-gaap:RetainedEarningsMember 2021-12-31 0000928054 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0000928054 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-09-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000928054 us-gaap:CommonStockMember 2022-01-01 2022-09-30 ftk:segment 0000928054 ftk:AssetBasedLoanMember us-gaap:LineOfCreditMember 2023-09-30 0000928054 ftk:AssetBasedLoanMember us-gaap:SubsequentEventMember us-gaap:LineOfCreditMember 2023-10-31 0000928054 ftk:ProFracAgreementMember 2023-01-01 2023-09-30 0000928054 ftk:BuildingAndLeaseholdMemberMember srt:MinimumMember 2023-09-30 0000928054 ftk:BuildingAndLeaseholdMemberMember srt:MaximumMember 2023-09-30 0000928054 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2023-09-30 0000928054 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2023-09-30 0000928054 us-gaap:FurnitureAndFixturesMember 2023-09-30 0000928054 us-gaap:LandImprovementsMember 2023-09-30 0000928054 us-gaap:TransportationEquipmentMember srt:MinimumMember 2023-09-30 0000928054 us-gaap:TransportationEquipmentMember srt:MaximumMember 2023-09-30 0000928054 ftk:ComputerEquipmentandSoftwareMember srt:MinimumMember 2023-09-30 0000928054 ftk:ComputerEquipmentandSoftwareMember srt:MaximumMember 2023-09-30 0000928054 srt:MinimumMember ftk:ChemistryTechnologiesSegmentMember 2023-09-30 0000928054 ftk:DataAnalyticsSegmentMember srt:MinimumMember 2023-09-30 0000928054 srt:MaximumMember ftk:ChemistryTechnologiesSegmentMember 2023-09-30 0000928054 ftk:DataAnalyticsSegmentMember srt:MaximumMember 2023-09-30 0000928054 ftk:DataAnalyticsSegmentMember srt:MinimumMember ftk:InternationalMember 2023-09-30 0000928054 srt:MinimumMember ftk:InternationalMember ftk:ChemistryTechnologiesSegmentMember 2023-09-30 0000928054 srt:MaximumMember ftk:InternationalMember ftk:ChemistryTechnologiesSegmentMember 2023-09-30 0000928054 ftk:DataAnalyticsSegmentMember srt:MaximumMember ftk:InternationalMember 2023-09-30 0000928054 us-gaap:ProductMember 2023-07-01 2023-09-30 0000928054 us-gaap:ProductMember 2022-07-01 2022-09-30 0000928054 us-gaap:ProductMember 2023-01-01 2023-09-30 0000928054 us-gaap:ProductMember 2022-01-01 2022-09-30 0000928054 us-gaap:ServiceMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember 2022-07-01 2022-09-30 0000928054 us-gaap:ServiceMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember 2022-01-01 2022-09-30 0000928054 us-gaap:ProductAndServiceOtherMember 2023-07-01 2023-09-30 0000928054 us-gaap:ProductAndServiceOtherMember 2022-07-01 2022-09-30 0000928054 us-gaap:ProductAndServiceOtherMember 2023-01-01 2023-09-30 0000928054 us-gaap:ProductAndServiceOtherMember 2022-01-01 2022-09-30 0000928054 ftk:ProFracAgreementMember 2022-02-02 0000928054 ftk:ProFracAgreementMember 2022-05-17 0000928054 ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 ftk:DataAnalyticsSegmentMember 2023-07-01 2023-09-30 0000928054 ftk:DataAnalyticsSegmentMember 2022-07-01 2022-09-30 0000928054 ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 ftk:DataAnalyticsSegmentMember 2023-01-01 2023-09-30 0000928054 ftk:DataAnalyticsSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:LandMember 2023-09-30 0000928054 us-gaap:LandMember 2022-12-31 0000928054 us-gaap:LandImprovementsMember 2022-12-31 0000928054 us-gaap:BuildingAndBuildingImprovementsMember 2023-09-30 0000928054 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0000928054 us-gaap:MachineryAndEquipmentMember 2023-09-30 0000928054 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000928054 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000928054 us-gaap:TransportationEquipmentMember 2023-09-30 0000928054 us-gaap:TransportationEquipmentMember 2022-12-31 0000928054 ftk:ComputerEquipmentandSoftwareMember 2023-09-30 0000928054 ftk:ComputerEquipmentandSoftwareMember 2022-12-31 xbrli:pure 0000928054 ftk:AssetBasedLoanMember us-gaap:LineOfCreditMember 2023-08-14 2023-08-14 0000928054 ftk:AssetBasedLoanMember us-gaap:LineOfCreditMember 2023-08-14 0000928054 ftk:AssetBasedLoanMember srt:MaximumMember us-gaap:LineOfCreditMember 2023-08-14 0000928054 ftk:AssetBasedLoanMember us-gaap:SubsequentEventMember us-gaap:LineOfCreditMember 2023-10-05 0000928054 ftk:AssetBasedLoanMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0000928054 ftk:AssetBasedLoanMember us-gaap:LineOfCreditMember 2023-07-01 2023-09-30 0000928054 ftk:AssetBasedLoanMember us-gaap:PrimeRateMember us-gaap:LineOfCreditMember 2023-08-14 2023-08-14 0000928054 ftk:AssetBasedLoanMember ftk:PeriodOneMember us-gaap:LineOfCreditMember 2023-08-14 2023-08-14 0000928054 ftk:AssetBasedLoanMember us-gaap:LineOfCreditMember ftk:PeriodTwoMember 2023-08-14 2023-08-14 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2020-04-01 2020-04-30 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2023-01-05 2023-01-05 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2023-01-04 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2023-01-05 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2023-01-01 2023-09-30 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2023-09-30 0000928054 us-gaap:UnsecuredDebtMember ftk:PaycheckProtectionProgramCARESActMember 2022-12-31 0000928054 ftk:PIPETransactionMember us-gaap:ConvertibleDebtMember 2022-02-02 0000928054 ftk:PIPETransactionMember us-gaap:ConvertibleDebtMember 2022-02-02 2022-02-02 ftk:day 0000928054 ftk:PIPETransactionMember us-gaap:ConvertibleDebtMember 2023-02-02 2023-02-02 0000928054 ftk:PIPETransactionMember us-gaap:ConvertibleDebtMember 2022-03-21 2022-03-21 0000928054 us-gaap:ConvertibleNotesPayableMember ftk:OtherConvertibleDebtMember 2023-02-02 0000928054 us-gaap:ConvertibleNotesPayableMember ftk:OtherConvertibleDebtMember 2023-02-02 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2023-02-02 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember ftk:February2023WarrantsMember 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember ftk:ProFracAgreementContractMember 2022-02-02 0000928054 us-gaap:ConvertibleDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember ftk:ProFracAgreementContractMember 2022-02-02 0000928054 us-gaap:ConvertibleDebtMember ftk:ProFracAgreementContractMember 2023-02-02 0000928054 us-gaap:RelatedPartyMember ftk:February2023WarrantsMember ftk:ProFracHoldingsLLCMember 2023-02-02 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember 2022-05-17 0000928054 us-gaap:ConvertibleDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember ftk:AmendedProFracAgreementMember 2022-05-17 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2023-05-17 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2023-05-17 2023-05-17 0000928054 us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember ftk:ReverseStockSplitMember 2023-05-17 2023-05-17 0000928054 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0000928054 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0000928054 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000928054 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000928054 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000928054 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000928054 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000928054 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000928054 us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0000928054 us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0000928054 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember 2023-09-30 0000928054 us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember 2023-09-30 0000928054 us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000928054 us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000928054 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember 2022-12-31 0000928054 us-gaap:FairValueMeasurementsRecurringMember ftk:ProFracAgreementMember 2022-12-31 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000928054 ftk:AmendedProFracAgreementMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000928054 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0000928054 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0000928054 us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0000928054 us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0000928054 us-gaap:MeasurementInputMaturityMember 2023-09-30 0000928054 us-gaap:MeasurementInputMaturityMember 2022-12-31 0000928054 us-gaap:MeasurementInputSharePriceMember 2023-09-30 0000928054 us-gaap:MeasurementInputSharePriceMember 2022-12-31 0000928054 us-gaap:MeasurementInputDiscountRateMember 2023-09-30 0000928054 us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0000928054 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-02 0000928054 us-gaap:ConvertibleDebtMember ftk:ProFracAgreementContractMember 2023-01-01 2023-09-30 0000928054 us-gaap:ConvertibleDebtMember ftk:ProFracAgreementContractMember 2022-07-01 2022-09-30 0000928054 us-gaap:ConvertibleDebtMember ftk:ProFracAgreementContractMember 2022-01-01 2022-09-30 0000928054 ftk:ProFracAgreementMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2022-12-31 0000928054 ftk:ProFracAgreementMember us-gaap:ConvertibleDebtMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0000928054 ftk:ProFracAgreementMember us-gaap:ConvertibleDebtMember us-gaap:MeasurementInputMaturityMember 2022-12-31 0000928054 us-gaap:MeasurementInputSharePriceMember ftk:ProFracAgreementMember us-gaap:ConvertibleDebtMember 2022-12-31 0000928054 ftk:ProFracAgreementMember us-gaap:ConvertibleDebtMember us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0000928054 us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember 2023-05-17 0000928054 us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember 2023-01-01 2023-09-30 0000928054 ftk:AmendedProFracAgreementMember 2022-07-01 2022-09-30 0000928054 ftk:AmendedProFracAgreementMember 2022-01-01 2022-09-30 0000928054 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember 2022-12-31 0000928054 us-gaap:ConvertibleDebtMember us-gaap:MeasurementInputPriceVolatilityMember ftk:AmendedProFracAgreementMember 2022-12-31 0000928054 us-gaap:ConvertibleDebtMember us-gaap:MeasurementInputMaturityMember ftk:AmendedProFracAgreementMember 2022-12-31 0000928054 us-gaap:MeasurementInputSharePriceMember us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember 2022-12-31 0000928054 us-gaap:ConvertibleDebtMember us-gaap:MeasurementInputDiscountRateMember ftk:AmendedProFracAgreementMember 2022-12-31 0000928054 ftk:ProFracAgreementMember 2023-07-01 2023-09-30 0000928054 ftk:ProFracAgreementMember 2022-07-01 2022-09-30 0000928054 ftk:ProFracAgreementMember 2023-01-01 2023-09-30 0000928054 ftk:ProFracAgreementMember 2022-01-01 2022-09-30 0000928054 ftk:AmendedProFracAgreementMember 2023-01-01 2023-09-30 0000928054 ftk:AmendedProFracAgreementMember 2023-07-01 2023-09-30 0000928054 ftk:EarnOutConsiderationFromBusinessCombinationMember 2023-07-01 2023-09-30 0000928054 ftk:EarnOutConsiderationFromBusinessCombinationMember 2022-07-01 2022-09-30 0000928054 ftk:EarnOutConsiderationFromBusinessCombinationMember 2023-01-01 2023-09-30 0000928054 ftk:EarnOutConsiderationFromBusinessCombinationMember 2022-01-01 2022-09-30 0000928054 ftk:ContingentPortionOfConvertibleDebtMember 2023-07-01 2023-09-30 0000928054 ftk:ContingentPortionOfConvertibleDebtMember 2023-01-01 2023-09-30 0000928054 us-gaap:DomesticCountryMember 2023-09-30 0000928054 us-gaap:StateAndLocalJurisdictionMember 2023-09-30 0000928054 ftk:PreviousCEOMember ftk:FormerCEOCaseMember 2023-01-01 2023-09-30 0000928054 2023-04-12 2023-04-12 0000928054 ftk:ReverseStockSplitMember 2023-09-25 2023-09-25 0000928054 2023-09-25 2023-09-25 0000928054 us-gaap:ScenarioAdjustmentMember 2023-09-30 0000928054 srt:RestatementAdjustmentMember 2022-12-31 0000928054 us-gaap:ConvertibleDebtMember ftk:AmendedProFracAgreementMember 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2023-09-06 2023-09-06 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember ftk:ReverseStockSplitMember 2023-09-06 2023-09-06 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:ProFracAgreementContractMember 2023-09-06 2023-09-06 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:ProFracAgreementContractMember ftk:ReverseStockSplitMember 2023-09-06 2023-09-06 0000928054 srt:AffiliatedEntityMember ftk:ProFracServicesLLCMember ftk:June2022WarrantsMember 2022-06-21 2022-06-21 0000928054 srt:AffiliatedEntityMember ftk:ProFracServicesLLCMember ftk:June2022WarrantsMember 2022-06-21 0000928054 srt:AffiliatedEntityMember ftk:ProFracServicesLLCMember ftk:June2022WarrantsMember ftk:ReverseStockSplitMember 2022-06-21 0000928054 srt:AffiliatedEntityMember ftk:ProFracServicesLLCMember ftk:June2022WarrantsMember 2023-02-02 0000928054 srt:AffiliatedEntityMember ftk:ProFracServicesLLCMember ftk:June2022WarrantsMember 2023-01-01 2023-09-30 0000928054 us-gaap:MeasurementInputRiskFreeInterestRateMember ftk:June2022WarrantsMember 2022-06-21 0000928054 us-gaap:MeasurementInputPriceVolatilityMember ftk:June2022WarrantsMember 2022-06-21 0000928054 us-gaap:MeasurementInputMaturityMember ftk:June2022WarrantsMember 2022-06-21 0000928054 us-gaap:MeasurementInputSharePriceMember ftk:June2022WarrantsMember 2022-06-21 0000928054 ftk:June2022WarrantsMember 2022-06-21 2022-06-21 0000928054 2023-09-14 2023-09-14 0000928054 us-gaap:ConvertibleNotesPayableMember 2023-07-01 2023-09-30 0000928054 us-gaap:ConvertibleNotesPayableMember 2022-07-01 2022-09-30 0000928054 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-09-30 0000928054 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-09-30 0000928054 us-gaap:WarrantMember 2023-07-01 2023-09-30 0000928054 us-gaap:WarrantMember 2022-07-01 2022-09-30 0000928054 us-gaap:WarrantMember 2023-01-01 2023-09-30 0000928054 us-gaap:WarrantMember 2022-01-01 2022-09-30 0000928054 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0000928054 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0000928054 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0000928054 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0000928054 us-gaap:WarrantMember 2023-01-01 2023-09-30 0000928054 us-gaap:WarrantMember 2022-01-01 2022-09-30 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:PIPETransactionMember 2022-02-02 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2022-05-17 ftk:fleet 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember 2022-05-17 2022-05-17 0000928054 us-gaap:RelatedPartyMember ftk:ProFracAgreementContractMember 2023-02-01 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:ProFracAgreementContractMember 2023-02-02 0000928054 us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember ftk:AmendedProFracAgreementMember ftk:ReverseStockSplitMember 2023-05-17 2023-05-17 0000928054 us-gaap:RelatedPartyMember ftk:ProFracServicesLLCMember 2023-07-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember ftk:ProFracServicesLLCMember 2022-07-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember ftk:ProFracServicesLLCMember 2023-01-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember ftk:ProFracServicesLLCMember 2022-01-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember ftk:ProFracServicesLLCMember 2023-09-30 0000928054 us-gaap:RelatedPartyMember ftk:ProFracServicesLLCMember 2022-12-31 0000928054 us-gaap:RelatedPartyMember us-gaap:ConvertibleNotesPayableMember 2022-03-21 2022-03-21 0000928054 us-gaap:RelatedPartyMember us-gaap:ConvertibleNotesPayableMember ftk:ReverseStockSplitMember 2022-03-21 2022-03-21 0000928054 srt:AffiliatedEntityMember ftk:ConfluenceMember srt:DirectorMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:ProductMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember us-gaap:ProductMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember us-gaap:ProductMember 2023-07-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:RelatedPartyMember us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:ChemistryTechnologiesSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:ProductMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember us-gaap:ProductMember ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember us-gaap:ProductMember 2022-07-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:ChemistryTechnologiesSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:ProductMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember us-gaap:ProductMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember us-gaap:ProductMember 2023-01-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:RelatedPartyMember us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:ServiceMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:ChemistryTechnologiesSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:ProductMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:ProductMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:ServiceMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:NonrelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:CorporateNonSegmentMember us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember us-gaap:ProductMember ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember us-gaap:ProductMember 2022-01-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember us-gaap:CorporateNonSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:ProductMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember us-gaap:RelatedPartyMember ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0000928054 us-gaap:RelatedPartyMember us-gaap:CorporateNonSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:ChemistryTechnologiesSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:ChemistryTechnologiesSegmentMember 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:ChemistryTechnologiesSegmentMember 2022-12-31 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember 2023-09-30 0000928054 us-gaap:OperatingSegmentsMember ftk:DataAnalyticsSegmentMember 2022-12-31 0000928054 us-gaap:CorporateNonSegmentMember 2023-09-30 0000928054 us-gaap:CorporateNonSegmentMember 2022-12-31 0000928054 country:US 2023-07-01 2023-09-30 0000928054 country:US 2022-07-01 2022-09-30 0000928054 country:US 2023-01-01 2023-09-30 0000928054 country:US 2022-01-01 2022-09-30 0000928054 us-gaap:NonUsMember 2023-07-01 2023-09-30 0000928054 us-gaap:NonUsMember 2022-07-01 2022-09-30 0000928054 us-gaap:NonUsMember 2023-01-01 2023-09-30 0000928054 us-gaap:NonUsMember 2022-01-01 2022-09-30 0000928054 ftk:CustomerMember us-gaap:RelatedPartyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0000928054 ftk:CustomerMember us-gaap:RelatedPartyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0000928054 ftk:CustomerMember us-gaap:RelatedPartyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0000928054 ftk:CustomerMember us-gaap:RelatedPartyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0000928054 ftk:CustomerBMember us-gaap:RelatedPartyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0000928054 ftk:SupplierAMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2023-07-01 2023-09-30 0000928054 ftk:SupplierBMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2023-07-01 2023-09-30 0000928054 ftk:SupplierCMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2023-07-01 2023-09-30 0000928054 ftk:SupplierAMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2022-07-01 2022-09-30 0000928054 ftk:SupplierBMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2022-07-01 2022-09-30 0000928054 ftk:SupplierCMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2022-07-01 2022-09-30 0000928054 ftk:SupplierAMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2023-01-01 2023-09-30 0000928054 ftk:SupplierBMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2023-01-01 2023-09-30 0000928054 ftk:SupplierCMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2023-01-01 2023-09-30 0000928054 ftk:SupplierAMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2022-01-01 2022-09-30 0000928054 ftk:SupplierBMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2022-01-01 2022-09-30 0000928054 ftk:SupplierCMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsSegmentMember 2022-01-01 2022-09-30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 10-Q
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| For the quarterly period ended September 30, 2023
or
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| For the transition period from to
| Commission File Number 1-13270

FLOTEK INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

Delaware |  | 90-0023731
(State of other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
5775 N. Sam Houston Parkway W., Suite 400, Houston, TX |  | 77086
(Address of principal executive offices) | (Zip Code)

(713) 849-9911
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $0.0001 par value | FTK | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒
Smaller reporting company ☒ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
At November 7, 2023, there were 29,662,759 outstanding shares of the registrant’s common stock, $0.0001 par value.

TABLE OF CONTENTS

Forward-Looking Statements | 3
PART I - FINANCIAL INFORMATION |
Item 1. | Financial Statements | 4
| Unaudited Condensed Consolidated Balance Sheets at September 30, 2023 and December 31, 2022 | 4
| Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 | 5
| Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023 and 2022 | 6
| Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 | 7
| Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2023 and 2022 | 8
| Notes to Unaudited Condensed Consolidated Financial Statements | 10
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 36
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 44
Item 4. | Controls and Procedures | 45
PART II - OTHER INFORMATION |
Item 1. | Legal Proceedings | 46
Item 1A | Risk Factors | 46
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 46
Item 3. | Defaults Upon Senior Securities | 46
Item 4. | Mine Safety Disclosures | 46
Item 5. | Other Information | 46
Item 6. | Exhibits | 47
SIGNATURES | 48

2

FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this “Quarterly Report”), and in particular, Part I, Item 2 — “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking statements” within the meaning of the safe harbor provisions, 15 U.S.C. § 78u-5, of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts, but instead represent the current assumptions and beliefs regarding future events of Flotek Industries, Inc. (“Flotek” or the “Company”), many of which, by their nature, are inherently uncertain and outside the Company’s control. Such statements include estimates, projections, and statements related to the Company’s business plan, objectives, expected operating results, and assumptions upon which those statements are based. The forward-looking statements contained in this Quarterly Report are based on information available as of the date of this Quarterly Report.
The forward-looking statements relate to future industry trends and economic conditions, forecast performance or results of current and future initiatives and the outcome of contingencies and other uncertainties that may have a significant impact on the Company’s business, future operating results and liquidity. These forward-looking statements generally are identified by words including but not limited to, “anticipate,” “believe,” “estimate,” “commit,” “budget,” “aim,” “potential,” “schedule,” “continue,” “intend,” “expect,” “plan,” “forecast,” “target,” “think,” “likely,” “project” and similar expressions, or future-tense or conditional constructions such as “will,” “may,” “should,” “could” and “would,” or the negative thereof or other variations thereon or comparable terminology. The Company cautions that these statements are merely predictions and are not to be considered guarantees of future performance. Forward-looking statements may also include statements regarding the anticipated performance under long-term supply agreements or amendments thereto and the potential value thereof or potential revenue or liquidated damages thereunder. Forward-looking statements are based upon current expectations and assumptions that are subject to risks and uncertainties that can cause actual results to differ materially from those projected, anticipated or implied.
A detailed discussion of potential risks and uncertainties that could cause actual results and events to differ materially from forward-looking statements include, but are not limited to, those discussed in Part I, Item 1A — “Risk Factors” of the Annual Report on Form 10-K for the year ended December 31, 2022 (“Annual Report” or “2022 Annual Report”) filed with the Securities and Exchange Commission (“SEC”) on March 23, 2023, and periodically in subsequent reports filed with the SEC. The Company has no obligation, and we disclaim any obligation, to publicly update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law.
In certain places in this Quarterly Report on Form 10-Q, we may refer to statements provided by third parties that purport to describe trends or developments in supply chain or energy exploration and production and activity and we specifically disclaim any responsibility for the accuracy and completeness of such information and have undertaken no steps to update or independently verify such information.
The following information contained in this Quarterly Report on Form 10-Q should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in Part 1, Item 1 of this Quarterly Report on Form 10-Q and related disclosures and our 2022 Annual Report.
3

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
FLOTEK INDUSTRIES INC, UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)

| September 30, 2023 |  | December 31, 2022
ASSETS |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 4,453 |  |  | $ | 12,290 |
Restricted cash | 102 |  |  | 100 |
Accounts receivable, net of allowance for credit losses of $704 and $623 at September 30, 2023 and December 31, 2022, respectively | 15,568 |  |  | 19,136 |
Accounts receivable, related party, net of allowance for credit losses of $0 at September 30, 2023 and December 31, 2022, respectively | 24,765 |  |  | 22,683 |
Inventories, net | 15,885 |  |  | 15,720 |
Other current assets | 4,617 |  |  | 4,045 |
Current contract assets | 7,816 |  |  | 7,113 |
Total current assets | 73,206 |  |  | 81,087 |
Long-term contract assets | 68,207 |  |  | 72,576 |
Property and equipment, net | 4,844 |  |  | 4,826 |
Operating lease right-of-use assets | 5,131 |  |  | 5,900 |
Deferred tax assets, net | 355 |  |  | 404 |
Other long-term assets | 773 |  |  | 17 |
TOTAL ASSETS | $ | 152,516 |  |  | $ | 164,810 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 33,436 |  |  | $ | 33,375 |
Accrued liabilities | 5,430 |  |  | 8,984 |
Income taxes payable | 43 |  |  | 97 |
Interest payable | — |  |  | 130 |
Current portion of operating lease liabilities | 2,747 |  |  | 3,328 |
Current portion of finance lease liabilities | 31 |  |  | 36 |
Asset-based loan | 3,370 |  |  | — |
Current portion of long-term debt | 179 |  |  | 2,052 |
Convertible notes payable | — |  |  | 19,799 |
Contract Consideration Convertible Notes Payable | — |  |  | 83,570 |
Total current liabilities | 45,236 |  |  | 151,371 |
Deferred revenue, long-term | 35 |  |  | 44 |
Long-term operating lease liabilities | 7,537 |  |  | 8,044 |
Long-term finance lease liabilities | — |  |  | 19 |
Long-term debt | 104 |  |  | 2,736 |
TOTAL LIABILITIES | 52,912 |  |  | 162,214 |
Stockholders’ equity: |  |  |
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding | — |  |  | — |
Common stock, $0.0001 par value, 240,000,000 shares authorized; 30,739,820 shares issued and 29,629,902 shares outstanding at September 30, 2023; 13,985,986 shares issued and 12,964,732 shares outstanding at December 31, 2022 (As adjusted, see Note 13) | 3 |  |  | 1 |
Additional paid-in capital (As adjusted, see Note 13) | 462,799 |  |  | 388,184 |
Accumulated other comprehensive income | 194 |  |  | 181 |
Accumulated deficit | (328,910) |  |  | (351,519) |
Treasury stock, at cost; 1,109,918 and 1,021,255 shares at September 30, 2023 and December 31, 2022, respectively (As adjusted, see Note 13) | (34,482) |  |  | (34,251) |
Total stockholders’ equity | 99,604 |  |  | 2,596 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 152,516 |  |  | $ | 164,810 |

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
4

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Revenue: |  |  |  |  |  |  |
Revenue from external customers | $ | 17,806 |  |  | $ | 15,206 |  |  | $ | 47,278 |  |  | $ | 38,412 |
Revenue from related party | 29,462 |  |  | 30,417 |  |  | 98,592 |  |  | 49,462 |
Total revenues | 47,268 |  |  | 45,623 |  |  | 145,870 |  |  | 87,874 |
Cost of sales | 38,221 |  |  | 47,465 |  |  | 131,037 |  |  | 92,500 |
Gross profit (loss) | 9,047 |  |  | (1,842) |  |  | 14,833 |  |  | (4,626) |
Operating costs and expenses: |  |  |  |  |  |  |
Selling, general, and administrative | 6,526 |  |  | 9,254 |  |  | 21,303 |  |  | 20,958 |
Depreciation | 181 |  |  | 177 |  |  | 530 |  |  | 554 |
Research and development | 757 |  |  | 985 |  |  | 2,231 |  |  | 3,515 |
Severance costs | 2 |  |  | (219) |  |  | (28) |  |  | 387 |
Gain on sale of property and equipment | (38) |  |  | (10) |  |  | (38) |  |  | (1,916) |
Gain on lease termination | — |  |  | — |  |  | — |  |  | (584) |
(Gain) loss in fair value of Contract Consideration Convertible Notes Payable | — |  |  | 4,250 |  |  | (29,969) |  |  | (9,016) |
Total operating costs and expenses | 7,428 |  |  | 14,437 |  |  | (5,971) |  |  | 13,898 |
Income (loss) from operations | 1,619 |  |  | (16,279) |  |  | 20,804 |  |  | (18,524) |
Other income (expense): |  |  |  |  |  |  |
Paycheck protection plan loan forgiveness | — |  |  | — |  |  | 4,522 |  |  | — |
Interest expense | (160) |  |  | (2,321) |  |  | (2,537) |  |  | (4,586) |
Other expense, net | (91) |  |  | (187) |  |  | (82) |  |  | (67) |
Total other income (expense) | (251) |  |  | (2,508) |  |  | 1,903 |  |  | (4,653) |
Income (loss) before income taxes | 1,368 |  |  | (18,787) |  |  | 22,707 |  |  | (23,177) |
Income tax expense | (81) |  |  | (7) |  |  | (98) |  |  | (101) |
Net income (loss) | $ | 1,287 |  |  | $ | (18,794) |  |  | $ | 22,609 |  |  | $ | (23,278) |
Income (loss) per common share (As adjusted, see Note 14): |  |  |  |  |  |
Basic | $ | 0.04 |  |  | $ | (1.50) |  |  | $ | 0.97 |  |  | $ | (1.89) |
Diluted | $ | 0.04 |  |  | $ | (1.50) |  |  | $ | (0.18) |  |  | $ | (1.89) |
Weighted average common shares (As adjusted, see Note 14): |  |  |  |  |  |
Weighted average common shares used in computing basic income (loss) per common share | 29,358 |  |  | 12,552 |  |  | 23,291 |  |  | 12,349 |
Weighted average common shares used in computing diluted income (loss) per common share | 30,688 |  |  | 12,552 |  |  | 28,034 |  |  | 12,349 |

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
5

FLOTEK INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Net income (loss) | $ | 1,287 |  |  | $ | (18,794) |  |  | $ | 22,609 |  |  | $ | (23,278) |
Other comprehensive income (loss): |  |  |  |  |  |  |
Foreign currency translation adjustment | 47 |  |  | 116 |  |  | 13 |  |  | 211 |
Comprehensive income (loss) | $ | 1,334 |  |  | $ | (18,678) |  |  | $ | 22,622 |  |  | $ | (23,067) |

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
6

FLOTEK INDUSTRIES, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (in thousands)

| Nine months ended September 30,
| 2023 |  | 2022
Cash flows from operating activities: |  |  |
Net income (loss) | $ | 22,609 |  |  | $ | (23,278) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: |  |  |
Change in fair value of contingent consideration | (384) |  |  | (106) |
Change in fair value of Contract Consideration Convertible Notes Payable | (29,969) |  |  | (9,016) |
Amortization of convertible note issuance cost | 83 |  |  | 663 |
Paid-in-kind interest expense | 2,284 |  |  | 3,861 |
Amortization of contract assets | 3,665 |  |  | 1,986 |
Depreciation | 530 |  |  | 554 |
Amortization of asset-based loan origination costs | 36 |  |  | — |
Provision for credit losses, net of recoveries | 97 |  |  | 147 |
Provision for excess and obsolete inventory | 626 |  |  | 1,702 |
Gain on sale of property and equipment | (38) |  |  | (1,916) |
Gain on lease termination | — |  |  | (584) |
Lease expense | 2,316 |  |  | 168 |
Stock compensation expense | (565) |  |  | 2,262 |
Deferred income tax benefit | 50 |  |  | 1 |
Paycheck protection plan loan forgiveness | (4,522) |  |  | — |
Changes in current assets and liabilities: |  |  |
Accounts receivable | 3,472 |  |  | (5,748) |
Accounts receivable, related party | (2,082) |  |  | (24,616) |
Inventories | (776) |  |  | (11,373) |
Income taxes receivable | — |  |  | 3 |
Other assets | (863) |  |  | (537) |
Contract assets | — |  |  | (3,600) |
Accounts payable | 60 |  |  | 22,036 |
Accrued liabilities | (3,179) |  |  | 493 |
Operating lease liabilities | (2,636) |  |  | (404) |
Income taxes payable | (54) |  |  | 100 |
Interest payable | (8) |  |  | 36 |
Net cash used in operating activities | (9,248) |  |  | (47,166) |
Cash flows from investing activities: |  |  |
Capital expenditures | (593) |  |  | (175) |
Proceeds from sale of assets | 68 |  |  | 4,215 |
Net cash (used in) provided by investing activities | (525) |  |  | 4,040 |
Cash flows from financing activities: |  |  |
Payment for forfeited stock options | (617) |  |  | — |
Payments on long term debt | (104) |  |  | — |
Proceeds from asset-based loan | 27,750 |  |  | — |
Payments on asset-based loan | (24,380) |  |  | — |
Payment of asset-based loan origination costs | (502) |  |  | — |
Proceeds from issuance of convertible notes | — |  |  | 21,150 |
Payment of issuance costs of convertible notes | — |  |  | (1,084) |
Proceeds from issuance of warrants | — |  |  | 19,500 |
Payment of issuance costs of stock warrants | — |  |  | (1,170) |
Payments to tax authorities for shares withheld from employees | (246) |  |  | (191) |
Proceeds from issuance of stock | 48 |  |  | 24 |
Payments for finance leases | (24) |  |  | (30) |
Net cash provided by financing activities | 1,925 |  |  | 38,199 |
Effect of changes in exchange rates on cash and cash equivalents | 13 |  |  | 211 |
Net change in cash and cash equivalents and restricted cash | (7,835) |  |  | (4,716) |
Cash and cash equivalents at the beginning of period | 12,290 |  |  | 11,534 |
Restricted cash at the beginning of period | 100 |  |  | 1,790 |
Cash and cash equivalents and restricted cash at beginning of period | 12,390 |  |  | 13,324 |
Cash and cash equivalents at end of period | 4,453 |  |  | 8,508 |
Restricted cash at the end of period | 102 |  |  | 100 |
Cash and cash equivalents and restricted cash at end of period | $ | 4,555 |  |  | $ | 8,608 |

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
7

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Three and six months ended September 30, 2023 and 2022
(In thousands of U.S. dollars and shares)

Three months ended September 30, 2023
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income |  | Accumulated Deficit |  |  |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
| (As adjusted, see Note 13) |  |  |  |  |
Balance, June 30, 2023 | 26,370 |  |  | $ | 3 |  |  | 1,113 |  |  | $ | (34,480) |  |  | $ | 462,529 |  |  | $ | 147 |  |  | $ | (330,197) |  |  |  |  | $ | 98,002 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,287 |  |  |  |  | 1,287 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 47 |  |  | — |  |  |  |  | 47 |
Stock issued under employee stock purchase plan | — |  |  | — |  |  | (4) |  |  | — |  |  | 15 |  |  | — |  |  | — |  |  |  |  | 15 |
Restricted stock granted | 145 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock forfeited | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 270 |  |  | — |  |  | — |  |  |  |  | 270 |
Shares withheld to cover taxes | (3) |  |  | — |  |  | — |  |  | (2) |  |  | (15) |  |  | — |  |  | — |  |  |  |  | (17) |
Exercise of February 2023 pre-funded warrants | 4,228 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Balance, September 30, 2023 | 30,740 |  |  | $ | 3 |  |  | 1,110 |  |  | $ | (34,482) |  |  | $ | 462,799 |  |  | $ | 194 |  |  | $ | (328,910) |  |  |  |  | $ | 99,604 |

Three months ended September 30, 2022
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income (Loss) |  | Accumulated Deficit |  |  |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
| (As adjusted, see Note 13) |  |  |  |  |
Balance, June 30, 2022 | 13,814 |  |  | $ | 1 |  |  | 1,019 |  |  | $ | (34,238) |  |  | $ | 386,317 |  |  | $ | 176 |  |  | $ | (313,698) |  |  |  |  | $ | 38,558 |
Net loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (18,794) |  |  |  |  | (18,794) |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 116 |  |  | — |  |  |  |  | 116 |
Restricted stock granted | 84 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock forfeited | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock units vested | 10 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 671 |  |  | — |  |  | — |  |  |  |  | 671 |
Shares withheld to cover taxes | (3) |  |  | — |  |  | 4 |  |  | (30) |  |  | (23) |  |  | — |  |  | — |  |  |  |  | (53) |
Balance, September 30, 2022 | 13,905 |  |  | $ | 1 |  |  | 1,024 |  |  | $ | (34,268) |  |  | $ | 386,965 |  |  | $ | 292 |  |  | $ | (332,492) |  |  |  |  | $ | 20,498 |

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
8

Nine months ended September 30, 2023
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income |  | Accumulated Deficit |  |  |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
| (As adjusted, see Note 13) |  |  |  |  |
Balance, December 31, 2022 | 13,986 |  |  | $ | 1 |  |  | 1,021 |  |  | $ | (34,251) |  |  | $ | 388,184 |  |  | $ | 181 |  |  | $ | (351,519) |  |  |  |  | $ | 2,596 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22,609 |  |  |  |  | 22,609 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 13 |  |  | — |  |  |  |  | 13 |
Stock issued under employee stock purchase plan | — |  |  | — |  |  | (12) |  |  | — |  |  | 48 |  |  | — |  |  | — |  |  |  |  | 48 |
Restricted stock granted | 148 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock forfeited | (7) |  |  | — |  |  | 65 |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock units vested | 82 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Forfeited stock options purchased | — |  |  | — |  |  | — |  |  | — |  |  | (617) |  |  | — |  |  | — |  |  |  |  | (617) |
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | (565) |  |  | — |  |  | — |  |  |  |  | (565) |
Shares withheld to cover taxes | (3) |  |  | — |  |  | 36 |  |  | (231) |  |  | (15) |  |  | — |  |  | — |  |  |  |  | (246) |
Exercise of pre-funded warrants | 4,228 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable to Pre-Funded Warrants | — |  |  | — |  |  | — |  |  | — |  |  | 15,092 |  |  | — |  |  | — |  |  |  |  | 15,092 |
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock | 10,583 |  |  | 2 |  |  | — |  |  | — |  |  | 40,636 |  |  | — |  |  | — |  |  |  |  | 40,638 |
Conversion of convertible notes payable to Pre-Funded Warrants | — |  |  | — |  |  | — |  |  | — |  |  | 11,040 |  |  | — |  |  | — |  |  |  |  | 11,040 |
Conversion of convertible notes payable to Common Stock | 1,723 |  |  | — |  |  | — |  |  | — |  |  | 8,996 |  |  | — |  |  | — |  |  |  |  | 8,996 |
Balance, September 30, 2023 | 30,740 |  |  | $ | 3 |  |  | 1,110 |  |  | $ | (34,482) |  |  | $ | 462,799 |  |  | $ | 194 |  |  | $ | (328,910) |  |  |  |  | $ | 99,604 |

Nine months ended September 30, 2022
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income |  | Accumulated Deficit |  |  |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
| (As adjusted, see Note 13) |  |  |  |  |
Balance, December 31, 2021 | 13,247 |  |  | $ | 1 |  |  | 1,004 |  |  | $ | (34,100) |  |  | $ | 363,424 |  |  | $ | 81 |  |  | $ | (309,214) |  |  |  |  | $ | 20,192 |
Net loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (23,278) |  |  |  |  | (23,278) |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 211 |  |  | — |  |  |  |  | 211 |
Stock issued under employee stock purchase plan | — |  |  | — |  |  | (3) |  |  | — |  |  | 24 |  |  | — |  |  | — |  |  |  |  | 24 |
Restricted stock granted | 189 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock forfeited | (1) |  |  | — |  |  | 4 |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Restricted stock units vested | 10 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |
Stock compensation expense | — |  |  | — |  |  |  |  | — |  |  | 2,262 |  |  | — |  |  | — |  |  |  |  | 2,262 |
Shares withheld to cover taxes | (6) |  |  | — |  |  | 19 |  |  | (168) |  |  | (23) |  |  | — |  |  | — |  |  |  |  | (191) |
Issuance of stock warrants, net of transaction fee | — |  |  | — |  |  | — |  |  | — |  |  | 9,930 |  |  | — |  |  | — |  |  |  |  | 9,930 |
Equity contribution | — |  |  | — |  |  | — |  |  | — |  |  | 8,400 |  |  | — |  |  | — |  |  |  |  | 8,400 |
Conversion of notes to common stock | 466 |  |  | — |  |  | — |  |  | — |  |  | 2,948 |  |  | — |  |  | — |  |  |  |  | 2,948 |
Balance, September 30, 2022 | 13,905 |  |  | $ | 1 |  |  | 1,024 |  |  | $ | (34,268) |  |  | $ | 386,965 |  |  | $ | 292 |  |  | $ | (332,492) |  |  |  |  | $ | 20,498 |

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
9

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 — Organization and Nature of Operations
General
Flotek Industries, Inc. (“Flotek” or the “Company”) creates unique solutions to reduce the environmental impact of energy on air, water, land and people. A technology-driven, specialty green chemistry and data company, Flotek helps customers across industrial and commercial markets improve their environmental performance.
The Company’s Chemistry Technologies (“CT”) segment develops, manufactures, packages, distributes, delivers, and markets green specialty chemicals that aim to enhance the profitability of hydrocarbon producers.
The Company’s Data Analytics (“DA”) segment aims to enable users to maximize the value of their hydrocarbon associated processes by providing analytics associated with their hydrocarbon streams in seconds rather than minutes or days. The real-time access to information prevents waste, reduces reprocessing and allows users to pursue automation of their hydrocarbon streams to maximize their profitability.
The Company’s two operating segments, CT and DA, are both supported by its Research & Innovation advanced laboratory capabilities. For further discussion of our operations and segments, see Note 17, “Business Segment, Geographic and Major Customer Information.”
Going Concern
These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company’s ability to continue as a going concern exists.
The Company currently funds its operations with cash on hand, availability under the Asset Based Loan (“ABL”) (see Note 9, “Debt and Convertible Notes Payable”) and other current assets. While the Company generated $22.6 million of net income in the nine months ended September 30, 2023, the Company has a recent history of losses and negative cash flows from operations and expects to utilize a significant amount of cash within one year after the date of filing the unaudited condensed consolidated financial statements. The availability of capital is dependent on the Company’s operating cash flow currently expected to be principally derived from the ProFrac Agreement (see Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions”). It is not certain that the Company’s cash, availability under the ABL and other current assets, along with the Company’s forecasted cash flows from operations, will provide the Company with sufficient financial resources to fund operations and meet the Company’s capital requirements and anticipated obligations as they become due in the next twelve months. The Company may require additional liquidity to continue its operations over the next twelve months to sufficiently alleviate or mitigate the conditions and events noted above, which results in substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are filed.
During the third quarter of 2023, the Company entered into the ABL providing up to $10.0 million of initial credit availability, which is limited by a borrowing base. In October 2023, the maximum credit availability under the ABL was increased by $3.8 million. However, the Company may be unable to access further equity or debt financing if needed. As such, there can be no assurance that the Company will be able to obtain additional liquidity when needed or under acceptable terms, if at all.
The unaudited condensed consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern.
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements reflect all adjustments, in the opinion of management, necessary for the fair statement of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The financial statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the SEC regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim financial statements should be read in conjunction with
10

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
the audited consolidated financial statements and notes included in the Company’s 2022 Annual Report. A copy of the 2022 Annual Report is available on the SEC’s website, www.sec.gov or on Flotek’s website, www.flotekind.com. The information contained on the Company’s website does not form a part of this Quarterly Report.
All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries.
Cash Equivalents
Cash equivalents consist of highly liquid investments with maturities of three months or less at the date of purchase.
Restricted Cash
The Company’s restricted cash is $0.1 million and $0.1 million as of September 30, 2023 and December 31, 2022, respectively. The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain in accordance with the terms of its credit card program with a financial institution.
Accounts Receivable and Allowance for Credit Losses
Accounts receivable and accounts receivable, related party, arise from product sales and services and are stated at estimated net realizable value. This value incorporates an allowance for credit losses to reflect any loss anticipated on accounts receivable balances. The Company applies the current expected credit loss (CECL) model, which requires immediate recognition of expected credit losses over the contractual life of receivables and records the appropriate allowance for credit losses as a charge to Operating Cost and Expenses. The allowance for credit losses is based on a combination of the individual customer circumstances, credit conditions, and historical write-offs and collections. The Company writes off specific accounts receivable when they are determined to be uncollectible. The recovery of accounts receivable previously written off is recorded as a reduction to the allowance for credit losses charged to operating expense.
The majority of the Company’s customers are engaged in the energy industry. The cyclical nature of the energy industry may affect customers’ operating performance and cash flows, which directly impact the Company’s ability to collect on outstanding obligations. Additionally, certain customers are located in international areas that are inherently subject to risks of economic, political, and civil instability, which can impact the collectability of receivables.
Contract Assets
The Company’s contract assets represent consideration issued in the form of convertible notes (Contract Consideration Convertible Notes Payable as discussed in Note 9, “Debt and Convertible Notes Payable”) and other incremental costs related to obtaining the ProFrac Agreement. The contract assets are amortized over the term of the ProFrac Agreement (10 years) based on forecasted revenues as goods are transferred to ProFrac Services, LLC, and the amortization is presented as a reduction of the transaction price included in related party revenue in the consolidated statements of operations.
The contract assets are tested for recoverability on a recurring basis and the Company will recognize an impairment loss to the extent that the carrying amount of the contract assets exceeds the amount of consideration the Company expects to receive in the future for the transfer of goods under the ProFrac Agreement less the direct costs that relate to providing those goods in the future.
Inventories
Inventories consist of raw materials and finished goods and are stated at the lower of cost determined by using the weighted-average cost method, or net realizable value. Finished goods inventories include raw materials, direct labor and production overhead. The Company periodically reviews inventories on hand and current market conditions to determine if the cost of raw materials and finished goods inventories exceed current market prices and impairs the cost basis of the inventory accordingly. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its net realizable value if those amounts are determined to be less than cost. Write-downs or write-offs of inventory are charged to cost of sales.
Property and Equipment
Property and equipment are stated at cost. The cost of ordinary maintenance and repair is charged to operating expense, while replacement of critical components and major improvements are capitalized. Depreciation or amortization of property and
11

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
equipment, including operating lease right-of-use assets (“ROU”), is calculated using the straight-line method over the shorter of the lease term or the asset’s estimated useful life as follows:

Buildings and leasehold improvements | 2-30 years
Machinery and equipment | 7-10 years
Furniture and fixtures | 3 years
Land improvements | 20 years
Transportation equipment | 2-5 years
Computer equipment and software | 3-7 years

Property and equipment, including ROU assets, are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. If events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable, the Company first compares the carrying amount of an asset or asset group to the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset. If the carrying amount of an asset or asset group exceeds the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset, the Company will determine the fair value of the asset or asset group. The amount of impairment loss recognized is the excess of the asset or asset group’s carrying amount over its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary.
Assets to be disposed of are reported as assets held for sale at the lower of the carrying amount or the asset’s fair value less cost to sell and depreciation is ceased. Upon sale or other disposition of an asset, the Company recognizes a gain or loss on disposal measured as the difference between the net carrying amount of the asset and the net proceeds received.
Leases
The Company leases certain facilities, land, vehicles, and equipment. The Company determines if an arrangement is classified as a lease at inception of the arrangement.
ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the related lease. Finance leases are under the current and non-current liabilities and the underlying assets are included in property and equipment on the consolidated balance sheet.
As most of the Company’s leases do not provide an implicit rate of return, on a quarterly basis, the Company’s incremental borrowing rate is used, together with the lease term information available at commencement date of the lease, in determining the present value of lease payments. Operating lease liabilities include related options to extend or terminate lease terms that are reasonably certain of being exercised.
Leases with an initial term of 12 months or less (“short term leases”) are not recorded on the balance sheet; and the lease expense on short-term leases is recognized on a straight-line basis over the lease term.
Convertible Notes Payable and Liability Classified Contract Consideration Convertible Notes Payable
The Company accounted for the Convertible Notes Payable at amortized cost pursuant to Financial Accounting Standards Board (“FASB”) ASC Topic 470, Debt.
The Company accounted for the Contract Consideration Convertible Notes Payable issued as consideration related to a related party contract (see Note 9, “Debt and Convertible Notes Payable”), as liability classified convertible instruments in accordance with FASB ASC 718, “Stock Compensation” (“ASC 718”). Under ASC 718, liability classified convertible instruments are measured at fair value at the grant date and at each reporting date (see Note 10, “Fair Value Measurements”) with the change in fair value included in the consolidated statements of operations.
As of September 30, 2023, the Convertible Notes Payable and Contract Consideration Convertible Notes Payable were converted through a series of transactions into the Company’s common stock. See Note 13, “Stockholders’ Equity” for additional information.
Fair Value Measurements
The Company categorizes financial assets and liabilities using a three-tier fair value hierarchy, based on the nature of the inputs used to determine fair value. Inputs refer broadly to assumptions that market participants would use to value an asset or liability
12

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
and may be observable or unobservable. When determining the fair value of assets and liabilities, the Company uses the most reliable measurement available. See Note 10, “Fair Value Measurements.”
Revenue Recognition
The Company recognizes revenue when it satisfies performance obligations under the terms of the contract with a customer, and control of the promised goods are transferred to the customer or services are performed, in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services.
The Company recognizes revenue based on a five-step model when all of the following criteria have been met: (i) a contract with a customer exists, (ii) performance obligations have been identified, (iii) the price to the customer has been determined, (iv) the price to the customer has been allocated to the performance obligations, and (v) performance obligations are satisfied.
Certain sales include discounts offered to customers for prompt payment and right of return provisions, which are considered when recognizing revenue and deferred accordingly. The Company does not act as an agent in any of its revenue arrangements.
In recognizing revenue for products and services, the Company determines the transaction price of contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services can be distinguished in the context of the contract.
The majority of the CT segment revenue is chemical products that are sold at a point in time based on when control transfers to the customer determined by agreed upon delivery terms. Contracts with customers for the sale of products generally state the terms of the sale, including the quantity and price of each product purchased. Additionally, the CT segment offers various services associated to products sold which includes field services, installation, maintenance, and other functions. These services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation when the Company has a right to invoice the customer.
The DA segment recognizes revenue for sales of equipment at the time of sale based on when control transfers to the customer based on agreed upon delivery terms. Additionally, the Company offers various services associated with products sold which includes field services, installation, maintenance, and other functions. Services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation. There may be additional performance obligations related to providing ongoing or reoccurring maintenance. Revenue for these types of arrangements is recognized ratably over time throughout the contract period. Additionally, the Company may provide subscription-type arrangements with customers in which monthly reoccurring revenue is recognized ratably over time in accordance with agreed upon terms and conditions. Customers may be invoiced for such maintenance and subscription-type arrangements, and revenue not yet recognizable is reported under accrued liabilities and deferred revenue on the consolidated balance sheets. Subscription-type arrangements were not a material revenue stream in the nine months ended September 30, 2023 and September 30, 2022.
Payment terms for both the CT and DA segments are customarily 30-60 days for domestic and 90-120 days for international from invoice receipt. Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Contract assets associated with incomplete performance obligations are not material.
The Company applies several practical expedients including:
•Sales commissions are expensed as selling, general and administrative expenses when incurred because the amortization period is generally one year or less.
•The Company’s payment terms are short-term in nature with settlements of one year or less. As a result, the Company does not adjust the promised amount of consideration for the effects of a significant financing component.
•In most service contracts, the Company has the right to consideration from a customer in an amount that corresponds directly with the value to the customer of the Company’s performance obligations completed to date and as such the Company recognizes revenue in the amount to which it has a right to invoice.
•The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. Such taxes are included in accrued liabilities on our consolidated balance sheet until remitted to the governmental agency.
13

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of sales in our consolidated statement of operations.
Foreign Currency Translation
The Company’s functional currency is primarily the U.S. dollar. The Company operates principally in the United States and substantially all assets and liabilities of the Company are denominated in U.S. dollars. Financial statements of foreign subsidiaries that are not U.S. dollar functional currency are prepared using the currency of the primary economic environment of the foreign subsidiaries as the functional currency. Assets and liabilities of those foreign subsidiaries are translated into U.S. dollars at exchange rates in effect as of the end of identified reporting periods. Revenue and expense transactions are translated using the average monthly exchange rate for the reporting period. Resultant translation adjustments are recognized as other comprehensive income (loss) within stockholders’ equity.
Comprehensive Income (Loss)
Comprehensive income (loss) encompasses all changes in stockholders’ equity, except those arising from investments and distributions to stockholders. The Company’s comprehensive income loss includes consolidated net income (loss) and foreign currency translation adjustments.
Research and Development Costs
Expenditures for research activities relating to product development and improvement are charged to expense as incurred.
Income Taxes
Deferred tax assets and liabilities are recognized for temporary differences between financial statement carrying amounts and the tax bases of assets and liabilities and are measured using the tax rates expected to be in effect when the differences reverse. Deferred tax assets are also recognized for operating loss and tax credit carry forwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date.
A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets.
The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
The Company’s policy is to record interest and penalties related to uncertain tax positions as income tax expense.
Stock-Based Compensation
Stock-based compensation expense, related to stock options, restricted stock awards and restricted stock units, is recognized based on their grant-date fair values. The Company recognizes compensation expense, net of estimated forfeitures, on a straight-line basis over the requisite service period of the award. Estimated forfeitures are based on historical experience.
Stock Warrants
The Company evaluated the Pre-Funded Warrants issued in June 2022 (the “June 2022 Warrants”) and the Pre-Funded Warrants issued in February 2023 (the “February 2023 Warrants”) (see Note 13, “Stockholders’ Equity) in accordance with ASC 815-40, “Contracts in Entity’s Own Equity” and determined that the June 2022 Warrants and the February 2023 Warrants meet the criteria to be classified within stockholders’ equity. Accordingly, the Company recorded the proceeds received for the June 2022 Warrants within additional paid in capital. In addition, the Company reclassified the balance of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”) upon conversion for the February 2023 Warrants within additional paid in capital.
14

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates.
Significant items subject to estimates and assumptions include the useful lives of property and equipment; long lived asset impairment assessments; stock-based compensation expense; allowance for credit losses for accounts receivable; valuation allowances for inventories and deferred tax assets; recoverability and timing of the realization of contract assets; and fair value of liability classified Contract Consideration Convertible Notes Payable.
Recent Accounting Pronouncements
Changes to U.S. GAAP are established by the FASB. We evaluate the applicability and impact of all authoritative guidance issued by the FASB. Guidance not listed below was assessed and determined to be either not applicable, clarifications of items listed below, immaterial or already adopted by the Company.
New Accounting Standards Issued and Adopted as of January 1, 2023
The FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments.” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects estimates of expected credit losses over their contractual life that are recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. The Company adopted this standard prospectively as of January 1, 2023 and the adoption did not have a material impact of the Company’s consolidated financial statements and related disclosures, and there was no cumulative effect on retained earnings.
New Accounting Standards Issued and Not Adopted
The Company has not identified any new issued accounting standards that are expected to have a material impact on the Company’s consolidated financial statements and related disclosures.
Note 3 — Revenue from Contracts with Customers
Disaggregation of Revenue
The Company differentiates revenue based on whether the source of revenue is attributable to product sales or service revenue.
Total revenue disaggregated by revenue source is as follows (in thousands):

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Revenue: |  |  |  |  |  |  |
Products (1) | $ | 45,865 |  |  | $ | 44,574 |  |  | $ | 141,695 |  |  | $ | 85,356 |
Services | 1,403 |  |  | 1,049 |  |  | 4,175 |  |  | 2,518 |
| $ | 47,268 |  |  | $ | 45,623 |  |  | $ | 145,870 |  |  | $ | 87,874 |

(1) Product revenue includes sales to related parties as described in Note 16, “Related Party Transactions.”
Disaggregation of Cost of Sales
The Company differentiates cost of sales based on whether the cost is attributable to tangible goods sold, cost of services sold or other costs which cannot be directly attributable to either tangible goods or services.
15

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Total cost of sales disaggregated is as follows (in thousands):

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Cost of sales: |  |  |  |  |  |  |
Tangible goods sold | $ | 33,350 |  |  | $ | 43,734 |  |  | $ | 116,755 |  |  | $ | 80,900 |
Services | 128 |  |  | 126 |  |  | 425 |  |  | 179 |
Other | 4,743 |  |  | 3,605 |  |  | 13,857 |  |  | 11,421 |
| $ | 38,221 |  |  | $ | 47,465 |  |  | $ | 131,037 |  |  | $ | 92,500 |

Other cost of sales represent costs directly associated with the generation of revenue but which cannot be attributed directly to tangible goods sold or services. Examples of other costs of sales are certain personnel costs and equipment rental and insurance costs.
Cost of sales split between external and related party sales is as follows (in thousands):

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Cost of sales: |  |  |  |  |  |  |
Cost of sales for external customers | $ | 14,399 |  |  | $ | 15,820 |  |  | $ | 42,471 |  |  | $ | 58,265 |
Cost of sales for related parties | 23,822 |  |  | 31,645 |  |  | 88,566 |  |  | 34,235 |
| $ | 38,221 |  |  | $ | 47,465 |  |  | $ | 131,037 |  |  | $ | 92,500 |

Note 4 - Contract Assets
Contract assets are as follows (in thousands):

| September 30, 2023 |  | December 31, 2022
Contract assets | $ | 83,060 |  |  | $ | 83,060 |
Less accumulated amortization | (7,037) |  |  | (3,371) |
Contract assets, net | 76,023 |  |  | 79,689 |
Less current contract assets | (7,816) |  |  | (7,113) |
Contract assets, long term | $ | 68,207 |  |  | $ | 72,576 |

In connection with entering into the ProFrac Agreement on February 2, 2022 and May 17, 2022 as discussed in Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions,” the Company recognized contract assets of $10.0 million and $69.5 million, respectively, and associated fees of $3.6 million. As of September 30, 2023 and December 31, 2022, $68.2 million and $72.6 million, respectively, of the contract assets are classified as long term based upon our estimate of the forecasted revenues from the ProFrac Agreement which will not be realized within the next twelve months of the ProFrac Agreement. The Company’s estimate of the timing of the future contract revenues is evaluated on a quarterly basis.
During the three and nine months ended September 30, 2023, the Company recognized $1.3 million and $3.7 million, respectively, of contract assets amortization which is recorded as a reduction of the transaction price included in the related party revenue in the consolidated statement of operations. During the three and nine months ended September 30, 2022, the Company recognized $1.2 million and $2.0 million, respectively, of contract assets amortization. The below table reflects our estimated amortization per year (in thousands) based on the Company’s current forecasted revenues from the ProFrac Agreement.
16

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Years ending December 31, |  | Amortization |  |
2023 (excluding the nine months ended September 30, 2023) | $ | 1,658 |  |  |
2024 |  | 8,432 |  |  |
2025 |  | 9,094 |  |  |
2026 |  | 9,094 |  |  |
2027 |  | 9,094 |  |  |
Thereafter through May 2032 |  | 38,651 |  |  |
Total contract assets |  | $ | 76,023 |  |  |

Based on our tests of recoverability, we did not recognize any impairment of such contract assets as of September 30, 2023.
Note 5 — Inventories
Inventories are as follows (in thousands):

| September 30, 2023 |  | December 31, 2022
Raw materials | $ | 5,603 |  |  | $ | 5,800 |
Finished goods | 17,475 |  |  | 18,130 |
Inventories | 23,078 |  |  | 23,930 |
Less reserve for excess and obsolete inventory | (7,193) |  |  | (8,210) |
Inventories, net | $ | 15,885 |  |  | $ | 15,720 |

The provision recorded in the three months ended September 30, 2023 and 2022 was $0.1 million and $44.8 thousand, respectively, for the CT segment and $16 thousand and $14.4 thousand, respectively, for the DA segment. The provision recorded in the nine months ended September 30, 2023 and 2022 was $0.5 million and $0.8 million, respectively, for the CT segment and $0.2 million and $0.1 million, respectively, for the DA segment.
Note 6 — Property and Equipment
Property and equipment are as follows (in thousands):

| September 30, 2023 |  | December 31, 2022
Land | $ | 886 |  |  | $ | 886 |
Land improvements | 520 |  |  | 520 |
Buildings and leasehold improvements | 5,356 |  |  | 5,356 |
Machinery and equipment | 6,687 |  |  | 6,758 |
Furniture and fixtures | 520 |  |  | 532 |
Transportation equipment | 784 |  |  | 784 |
Computer equipment and software | 1,801 |  |  | 1,425 |
Property and equipment | 16,554 |  |  | 16,261 |
Less accumulated depreciation | (11,710) |  |  | (11,435) |
Property and equipment, net | $ | 4,844 |  |  | $ | 4,826 |

Depreciation expense totaled $0.2 million and $0.2 million for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense totaled $0.5 million and $0.6 million for the nine months ended September 30, 2023 and 2022, respectively.
17

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 7 — Leases
The components of lease expense and supplemental cash flow information are as follows (in thousands):

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Operating lease expense | $ | 890 |  |  | $ | 217 |  |  | $ | 2,625 |  |  | $ | 880 |
Finance lease expense: |  |  |  |  |  |  |
Amortization of assets | 3 |  |  | 4 |  |  | 11 |  |  | 11 |
Interest on lease liabilities | 1 |  |  | 1 |  |  | 3 |  |  | 5 |
Total finance lease expense | 4 |  |  | 5 |  |  | 14 |  |  | 16 |
Short-term lease expense | 138 |  |  | 76 |  |  | 160 |  |  | 341 |
Total lease expense | $ | 1,032 |  |  | $ | 298 |  |  | $ | 2,799 |  |  | $ | 1,237 |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |
Operating cash flows from operating leases | $ | 1,331 |  |  | $ | 461 |  |  | $ | 4,246 |  |  | $ | 1,186 |
Operating cash flows from finance leases | 7 |  |  | 10 |  |  | 24 |  |  | 32 |
Financing cash flows from finance leases | 1 |  |  | 1 |  |  | 3 |  |  | 5 |

Maturities of lease liabilities as of September 30, 2023 are as follows (in thousands):

Years ending December 31, |  | Operating Leases |  | Finance Leases
2023 (excluding the nine months ended September 30, 2023) | $ | 985 |  |  | $ | 10 |
2024 |  | 2,909 |  |  | 22 |
2025 |  | 1,696 |  |  | — |
2026 |  | 1,732 |  |  | — |
2027 |  | 1,660 |  |  | — |
Thereafter |  | 4,334 |  |  | — |
Total lease payments |  | $ | 13,316 |  |  | $ | 32 |
Less: Interest |  | (3,032) |  |  | (1) |
Present value of lease liabilities |  | $ | 10,284 |  |  | $ | 31 |

18

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Supplemental balance sheet information related to leases is as follows (in thousands):

| September 30, 2023 |  | December 31, 2022 |  |
Operating Leases |  |  |  |  |
Operating lease right-of-use assets | $ | 5,131 |  |  | $ | 5,900 |  |  |
Current portion of operating lease liabilities | 2,747 |  |  | 3,328 |  |  |
Long-term operating lease liabilities | 7,537 |  |  | 8,044 |  |  |
Total operating lease liabilities | $ | 10,284 |  |  | $ | 11,372 |  |  |
Finance Leases |  |  |  |  |
Property and equipment | $ | 147 |  |  | $ | 147 |  |  |
Accumulated depreciation | (66) |  |  | (55) |  |  |
Property and equipment, net | $ | 81 |  |  | $ | 92 |  |  |
Current portion of finance lease liabilities | $ | 31 |  |  | $ | 36 |  |  |
Long-term finance lease liabilities | — |  |  | 19 |  |  |
Total finance lease liabilities | $ | 31 |  |  | $ | 55 |  |  |
Weighted Average Remaining Lease Term |  |  |  |  |
Operating leases | 4.6 years |  | 5.3 years |  |
Finance leases | 0.8 years |  | 1.6 years |  |
Weighted Average Discount Rate |  |  |  |  |
Operating leases | 9.2 | % |  | 9.3 | % |  |
Finance leases | 8.5 | % |  | 8.9 | % |  |

Sublease Income
On April 1, 2023, the Company entered into an agreement to sublease its office and lab space in Houston, Texas beginning September 1, 2023 and continuing until October 30, 2030. The rental income from the sublease is included in the Company’s statement of operations in Other income (expense), net, and offsets the rental expense from the Company’s lease of the facility from the landlord. Sublease rental income for future years are as follows (in thousands):

Years ending December 31, |  | Rental Income
2023 (excluding the nine months ended September 30, 2023) | $ | 192 |
2024 |  | 767 |
2025 |  | 767 |
2026 |  | 767 |
2027 |  | 767 |
Thereafter |  | 2,173 |
Total rental income |  | $ | 5,433 |

19

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 8 — Accrued Liabilities
Current accrued liabilities are as follows (in thousands):

| September 30, 2023 |  | December 31, 2022
Severance costs | $ | 935 |  |  | $ | 2,617 |
Payroll and benefits | 1,420 |  |  | 684 |
Legal costs | 237 |  |  | 447 |
Contingent liability for earn-out provision | 199 |  |  | 583 |
Deferred revenue, current | 754 |  |  | 655 |
Taxes other than income taxes | 450 |  |  | 1,884 |
Other | 1,435 |  |  | 2,114 |
Total current accrued liabilities | $ | 5,430 |  |  | $ | 8,984 |

Note 9 — Debt and Convertible Notes Payable
Asset Based Loan
On August 14, 2023, the Company entered into a 24-month revolving loan and security agreement in connection with the ABL. The ABL is classified as current debt on our consolidated balance sheet due to the nature of the payment arrangements outlined within the ABL whereby the lender is paid from customer payments received into the Company’s collections account. The ABL provides up to $10 million of initial credit availability, which is limited by a borrowing base consisting of:
•85% of eligible accounts receivable, plus
•60% of the value of eligible inventory not to exceed 100% of the eligible accounts receivable.
Under the initial terms of the ABL, the maximum credit availability could be increased based on the lesser of (i) 50% of the appraised value of real estate collateral held by the Company and (ii) $5 million. On October 5, 2023, the ABL was amended to increase its maximum borrowing base from $10 million to $13.8 million (the “Amended ABL”) subsequent to the appraisal of the real estate.
As of September 30, 2023, the Company had $3.4 million outstanding under the ABL. During the three and nine months ended September 30, 2023, the Company paid $0.2 million in interest and fees related to the ABL, which included the annual fee of $0.1 million. As of September 30, 2023, the Company had incurred origination costs of $0.5 million related to the ABL that was recorded as deferred financing costs to be amortized over the term of the ABL.
Borrowings under the ABL bear interest at the Wall Street Journal Prime Rate (subject to a floor of 5.50%) plus 2.5% per annum. The interest rate under the ABL was 11.0% as of September 30, 2023. The ABL contains an annual commitment fee equal to 1.0% of the ABL’s borrowing base. Additionally, the Company will be assessed a non-usage fee of 0.25% per quarter based on the difference between the average daily outstanding balance and the borrowing base limit of the ABL. If the ABL is terminated prior to the end of its 24-month term, the Company is required to pay an early termination fee of 2.50% of the borrowing base limit of the ABL (if terminated with more than 12 months remaining until the maturity date) or 1.50% of the borrowing base limit of the ABL (if terminated with less than 12 months remaining until the maturity date).
The ABL contains customary representations, warranties, covenants and events of default, the occurrence of which would permit the lender to accelerate the payment of any amounts borrowed. The ABL requires the Company to maintain a minimum Tangible Net Worth (as defined in the ABL) of not less than $11.0 million. In addition, the ABL provides the lender a blanket security interest on all or substantially all of the Company’s assets. The Company was in compliance with all of the covenants under the ABL as of September 30, 2023.
Paycheck Protection Program Loan
In April 2020, the Company received a $4.8 million loan (the “Flotek PPP loan”) under the Paycheck Protection Program (“PPP”), which was created through the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). In October 2021, the Flotek PPP loan maturity date was extended from April 15, 2022 to April 15, 2025. On January 5, 2023, the Company received notice from the SBA that $4.4 million of the $4.8 million principal amount and accrued interest to that date of $0.1 million were forgiven. The remaining
20

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
principal amount of $0.4 million and accrued interest is to be repaid in monthly installments of $15 thousand over the remaining term of the loan through April 15, 2025, beginning on March 15, 2023. The forgiveness of the Flotek PPP loan is accounted for as an extinguishment of the debt and the Company has recorded a $4.5 million gain in the nine months ended September 30, 2023, comprising the principal amount forgiven of $4.4 million and accrued interest of $0.1 million.
Long-term debt, including current portion, is as follows (in thousands):

| September 30, 2023 |  | December 31, 2022
Flotek PPP loan | $ | 283 |  |  | $ | 4,788 |
Less current maturities | (179) |  |  | (2,052) |
Total long-term debt, net of current portion | $ | 104 |  |  | $ | 2,736 |

Loan repayments are scheduled as follows (in thousands):

Years ending December 31, |  | Repayment
2023 (excluding the nine months ended September 30, 2023) | $ | 45 |
2024 |  | 181 |
2025 |  | 57 |
Total Flotek PPP loan |  | $ | 283 |

Convertible Notes Payable
On February 2, 2022, Flotek entered into a Private Investment in Public Equity transaction (the “PIPE transaction”) with a consortium of investors to secure growth capital for the Company. Pursuant to the PIPE transaction, Flotek issued $21.2 million in aggregate initial principal amount of Convertible Notes Payable for net cash proceeds of approximately $20.1 million (the “Convertible Notes Payable”). The investors were ProFrac Holdings, LLC, Burlington Ventures Ltd., entities associated with North Sound Management, certain funds associated with one of Flotek's directors including the D3 Family Fund and the D3 Bulldog Fund, and Firestorm Capital LLC. The Convertible Notes Payable accrued paid-in-kind interest at a rate of 10% per annum, had a maturity of one year, and were convertible into common stock of Flotek or Pre-Funded Warrants to purchase common stock of Flotek, (a) at the holder's option at any time prior to maturity, at a price of $1.088125 per share on a pre-Reverse Stock Split basis, (b) at Flotek's option, if the volume-weighted average trading price of Flotek's common stock equals or exceeds $2.50 per share on a pre-Reverse Stock Split basis, or $1.741 per share on a pre-Reverse Stock Split basis, for 20 trading days during a 30 consecutive trading day period, or (c) at maturity, at a price of $0.8705 per share on a pre-Reverse Stock Split basis. On March 21, 2022, $3.0 million of the Convertible Notes Payable, plus accrued paid-in-kind interest thereon, were converted at the holder’s option into approximately 2.8 million shares of common stock on a pre-Reverse Stock Split basis. The issuance cost of $1.1 million was amortized on a straight-line basis over the term of the Convertible Notes Payable and the amortization was included in interest expense in the unaudited condensed consolidated statements of operations.
On February 2, 2023, the Convertible Notes Payable, excluding those held by ProFrac Holdings, LLC, with a carrying value of $9.0 million, including accrued paid-in-kind interest of $0.8 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 10,335,840 shares of common stock at a price of $0.8705 per share.
The Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued paid-in-kind interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants with an exercise price of $0.0001 per share.
Initial ProFrac Agreement Contract Consideration Convertible Notes Payable
On February 2, 2022, the Company entered into a long-term supply agreement with ProFrac Services, LLC (the “Initial ProFrac Agreement”), a subsidiary of ProFrac Holdings LLC, in exchange for $10 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (“Initial ProFrac Agreement Contract Consideration Convertible Notes Payable”), under the same terms as the Convertible Notes Payable issued in the PIPE transaction described above, including paid-in-kind interest at a rate of 10% per annum and conversion features.
21

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were accounted for as liability classified convertible instruments and were initially recorded at fair value of $10.0 million on the issuance date with a corresponding contract asset.
On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, remeasured to and carried at a fair value of $15.1 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants with an exercise price of $0.0001 per share (see Note 10, “Fair Value Measurements”).
Amended ProFrac Agreement Contract Consideration Convertible Notes Payable
On May 17, 2022, the Company entered into an amendment to the Initial ProFrac Agreement (the “Amended ProFrac Agreement” and collectively with the Initial ProFrac Agreement, the “ProFrac Agreement”) upon issuance of $50 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (“Amended ProFrac Agreement Contract Consideration Convertible Notes Payable”) to ProFrac. The Amended ProFrac Agreement Contract Consideration Convertible Notes Payable accrued paid-in-kind interest at a rate of 10% per annum.
The Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were accounted for as liability classified convertible instruments and were initially recorded at fair value of $69.5 million on the issuance date with a corresponding contract asset.
On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable, remeasured to and carried at a fair value of $40.6 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (see Note 10, “Fair Value Measurements”). As a result of the Reverse Stock Split, these shares were converted into 10,582,821 common shares.
Note 10 — Fair Value Measurements
Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement.
•Level 1 — Quoted prices in active markets for identical assets or liabilities;
•Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
•Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.
Fair Value of Other Financial Instruments
The carrying amounts of certain financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accrued liabilities, accounts payable and ABL approximate fair value due to the short-term nature of these accounts.
22

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the Company’s liabilities that are measured at fair value on a recurring basis and the level within the fair value hierarchy (in thousands):

|  |  |  |  |  | September 30, |  |  |  |  |  |  |  | December 31,
| Level 1 |  | Level 2 |  | Level 3 | 2023 |  | Level 1 |  | Level 2 |  | Level 3 |  | 2022
Contingent earnout consideration | $ | — |  |  | $ | — |  |  | $ | 199 |  | $ | 199 |  |  | $ | — |  |  | $ | — |  |  | $ | 583 |  |  | $ | 583 |
Initial ProFrac Agreement Contract Consideration Convertible Notes | — |  |  | — |  |  | — |  | — |  |  | — |  |  | — |  |  | 14,220 |  |  | 14,220 |
Amended ProFrac Agreement Contract Consideration Convertible Notes | — |  |  | — |  |  | — |  | — |  |  | — |  |  | — |  |  | 69,350 |  |  | 69,350 |
Total | $ | — |  |  | $ | — |  |  | $ | 199 |  | $ | 199 |  |  | $ | — |  |  | $ | — |  |  | $ | 84,153 |  |  | $ | 84,153 |

Contingent Earnout Consideration Key Inputs
The estimated fair value of the remaining stock performance earn-out provision, with respect to the JP3 transaction, is included in accrued liabilities as of September 30, 2023 and December 31, 2022. The estimated fair value of the earn-out provision at the end of each period was valued using a Monte Carlo model analyzing 20,000 simulations performed using Geometric Brownian Motion with inputs such as risk-neutral expected growth and volatility.

| September 30, 2023 | December 31, 2022
Risk-free interest rate | 5.19 | % | 4.34 | %
Expected volatility | 90.0 | % | 100.0 | %
Term until liquidation (years) | 1.63 |  | 2.38 |
Stock price (pre-Reverse Stock Split basis) | $ | 4.43 |  | $ | 1.12 |
Discount rate | 13.31 | % | 9.95 | %

Initial ProFrac Agreement Contract Consideration Notes Payable Key Inputs
The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were measured at fair value at issuance and on a recurring basis. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable had an initial fair value of $10.0 million on February 2, 2022. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were classified as Level 2 at the initial measurement upon issuance due to the use of a quoted price for a similar liability at that date (the PIPE transaction), and subsequently classified as Level 3 due to the use of unobservable inputs.
On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were remeasured, upon maturity, to a fair value of $15.1 million based on the pre-Reverse Stock Split closing price of the shares of common stock of $1.19, on the date of conversion. The fair value adjustment was a $0.8 million increase for the nine months ended September 30, 2023, and a $0.6 million increase and a $1.9 million increase in the three and nine months ended September 30, 2022, respectively.
23

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The estimated value of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable as of December 31, 2022 was valued using a Monte Carlo simulation. The key inputs into the Monte Carlo simulation used to estimate the fair value of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable maturing February 2, 2023, as of December 31, 2022 were as follows:

|  | December 31, 2022
Risk-free interest rate |  | 4.12%
Expected volatility |  | 100.0%
Term until liquidation (years) |  | 0.09
Stock price (pre-Reverse Stock Split basis) |  | $1.12
Discount rate |  | 4.12%

Amended ProFrac Agreement Contract Consideration Convertible Notes Payable Key Inputs
On May 17, 2022, the Company measured the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable classified as Level 3 using a Monte Carlo simulation at an estimated fair value of $69.5 million. The Company reduced the discount rate assumed due to the reduced likelihood of occurrence of any of the default events in the shorter term remaining on the notes. The estimated value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable as of December 31, 2022 was valued using a Monte Carlo simulation.
On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were remeasured, at maturity, to a fair value of $40.6 million based on the pre-Reverse Stock Split closing price of the shares of common stock of $0.64, on the date of conversion. The fair value adjustment was a decrease of $30.8 million in the nine months ended September 30, 2023. There was no fair value adjustment for the three months ended September 30, 2023. The fair value adjustment was an increase of $3.6 million and a decrease of $10.9 million in the three and nine months ended September 30, 2022, respectively.
The key inputs into the Monte Carlo simulation used to estimate the fair value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable maturing May 17, 2023, as of December 31, 2022 were as follows:

| December 31, 2022
Risk-free interest rate | 4.59%
Expected volatility | 100.0%
Term until liquidation (years) | 0.38
Stock price (pre-Reverse Stock Split basis) | $1.12
Discount rate | 4.59%

Assets Measured at Fair Value on a Nonrecurring Basis
The Company’s non-financial assets, including property and equipment and operating lease ROU assets, are measured at fair value on a non-recurring basis and are subject to adjustment to their fair value in certain circumstances.
24

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Level 3 Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the changes in balances of liabilities for the three and nine months ended September 30, 2023 and 2022 classified as Level 3 (in thousands):

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Balance - beginning of period | $ | 260 |  |  | $ | 67,694 |  |  | $ | 84,153 |  |  | $ | 608 |
Transfer of ProFrac Agreement Contract Consideration Convertible Notes Payable from Level 2 | — |  |  | — |  |  | — |  |  | 10,000 |
Issuance of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable | — |  |  | — |  |  | — |  |  | 69,460 |
Increase in principal of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest | — |  |  | 266 |  |  | 85 |  |  | 681 |
Increase in principal of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest |  |  | 1,293 |  |  | 2,043 |  |  | 1,905 |
Change in fair value of contingent earnout consideration | (61) |  |  | 28 |  |  | (384) |  |  | (106) |
Change in fair value of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable | — |  |  | 634 |  |  | 786 |  |  | 1,889 |
Change in fair value of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable | — |  |  | 3,617 |  |  | (30,754) |  |  | (10,905) |
Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable on maturity | — |  |  | — |  |  | (15,092) |  |  | — |
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable on maturity |  |  | — |  |  | (40,638) |  |  | — |
Balance - end of period | $ | 199 |  |  | $ | 73,532 |  |  | $ | 199 |  |  | $ | 73,532 |

Note 11 — Income Taxes
The income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21% to income (loss) before income tax for the reasons set forth below:

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
U.S. federal statutory tax rate | 21.0 | % |  | 21.0 | % |  | 21.0 | % |  | 21.0 | %
State income taxes, net of federal benefit | 6.1 |  |  | — |  |  | 0.4 |  |  | — |
Non-U.S. income taxed at different rates | 7.3 |  |  | 0.2 |  |  | 0.5 |  |  | (0.3) |
Increase (reduction) in tax benefit related to stock-based awards | 0.7 |  |  | — |  |  | 0.7 |  |  | (0.4) |
Increase in valuation allowance | (5.6) |  |  | (21.7) |  |  | (19.0) |  |  | (20.7) |
Permanent differences | (16.7) |  |  | — |  |  | (3.0) |  |  | — |
Non-deductible expenses | (6.6) |  |  | 0.5 |  |  | (0.2) |  |  | 0.4 |
2018 IRS exam assessment | — |  |  | — |  |  | — |  |  | (0.4) |
Effective income tax rate | 6.2 | % |  | — | % |  | 0.4 | % |  | (0.4) | %

Internal Revenue Code (“IRC”) section 382 addresses company ownership changes and specifically limits the utilization of certain deductions and other tax attributes on an annual basis following an ownership change. During 2023, the Company converted various debt instruments into Company stock and warrants causing an ownership change within the meaning of IRC section 382 that subjected certain of the Company’s tax attributes, including net operating losses ("NOLs"), to an IRC section 382 limitation.
25

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
As of September 30, 2023, the Company has an estimated $196.6 million in U.S. federal NOL carryforwards, $119.8 million in certain state NOL carryforwards, $7.2 million in section 163(j) interest limitation carryforwards and $3.8 million in tax credit carryforwards. As a result of the change of control experienced in 2023, the Company’s ability to use NOLs to reduce taxable income is generally limited to an amount currently estimated to be $3.5 million a year as a result of the section 382 limitation which may be revised based on further detailed analysis. NOLs that exceed the section 382 limitation in any year continue to be allowed as carryforwards until they expire and can be used to offset taxable income for years within the carryover period subject to the limitation in each year. The Company’s use of new NOLs arising after the date of the change of control would not be impacted by the 382 limitation. Federal NOLs incurred prior to 2018 generally have a 20-year life until they expire in varying amounts between 2029 and 2037. Federal NOLs generated in 2018 and after are carried forward indefinitely. State NOLs have various carryforward periods depending on the legislation in the respective state jurisdiction. If the Company does not generate a sufficient level of taxable income prior to the expiration of the pre-2018 NOL carryforward periods, then the ability to apply those NOLs as offsets to future taxable income is lost. Based on the preliminary section 382 limitation, the Company estimates that $41.9 million of the state NOL carryforwards and $3.8 million of the tax credit carryforwards will expire unutilized. The tax effected amount of the estimated expirations is included in the Company’s valuation allowance.
Note 12 — Commitments and Contingencies
Litigation
The Company is subject to routine litigation and other claims that arise in the normal course of business. Except as disclosed below, management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity.
Former CEO (John Chisholm) Matter
On May 23, 2023, the Company entered into an agreement with John Chisholm (a former CEO of the Company) to resolve a claim made by Mr. Chisholm in arbitration for payment of outstanding severance and claims made by the Company against Mr. Chisholm. The settlement resulted in the reversal of $2.3 million of accrued severance costs during the nine months ended September 30, 2023 and is included in severance costs in our consolidated statements of operation. The Company had withheld payment of outstanding severance to Mr. Chisholm subsequent to an investigation conducted during the year ended December 31, 2021 into corporate practices when Mr. Chisholm was CEO during the years from 2014 to 2018. The Company concluded upon completion of that investigation that its historical financial statements could be relied upon, that proper action had been taken, and that no members of current management were implicated in any improper corporate practices. The Company subsequently commenced arbitration and other legal proceedings against Mr. Chisholm, Casey Doherty/ Doherty & Doherty LLP (Flotek’s former outside general counsel) and Moss Adams LLP and its predecessor, Hein & Associates LLP (Flotek’s former independent public audit firm) to recover damages. Mr. Chisholm filed a counterclaim against the Company in the arbitration proceeding for his remaining severance, and that dispute has been resolved as previously stated. During June 2023, the Company entered into a settlement with Moss Adams LLP and its predecessor, Hein & Associates LLP. During October 2023, the Company entered into a settlement with Mr. Casey Doherty and Doherty & Doherty LLP.
Other Commitments and Contingencies
The Company is subject to concentrations of credit risk within trade accounts receivable, and related party accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in three major U.S. financial institutions and balances often exceed insurable amounts.
Note 13 — Stockholders’ Equity
Reverse stock split
The Company’s common stock is currently listed on the NYSE. On April 12, 2023, the Company received written notice from the NYSE that the average closing price of the Company’s shares of common stock was below $1.00 per share over a period of 30 consecutive days, which is below the requirement for continued listing on the NYSE. In accordance with applicable NYSE procedures, the Company notified the NYSE that it intended to cure the $1.00 per share deficiency.
On September 14, 2023, the Company announced that the Board of Directors approved a reverse stock split of its common stock at a ratio of 1-to-6 (“Reverse Stock Split”). The Reverse Stock Split was completed on September 25, 2023 and resulted in 184,438,695 issued and outstanding shares of common stock being converted into 30,739,820 shares of common stock.
26

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Reverse Stock Split had no effect on the par value or on the number of authorized shares of common stock. The Company issued one whole share of common stock to any shareholder that would have received a fractional share as a result of the Reverse Stock Split. Therefore, no fractional shares were issued in connection with the Reverse Stock Split and no cash or other consideration was paid in connection with any fractional shares that resulted from the Reverse Stock Split.
As the par value per share of common stock was not changed in connection with the Reverse Stock Split, we recorded a decrease of $15 thousand and $7 thousand to common stock on our consolidated balance sheet with a corresponding increase in additional paid-in capital as of September 30, 2023 and December 31, 2022, respectively. We also adjusted the number of outstanding shares of common stock and treasury stock on the consolidated balance sheet and in the statement of changes in stockholders’ equity for all periods presented to reflect the impacts of the Reverse Stock Split. Where we disclose the number of shares of common stock within the footnotes to the consolidated financial statements we have presented both the pre-Reverse Stock Split and post-Reverse Stock Split amount as denoted.
Unless otherwise noted, all references in the consolidated financial statements and notes to consolidated financial statements to the number of shares, per share data, restricted stock and stock option data have been retroactively adjusted to give effect to the Reverse Stock Split.
Conversion of Convertible Notes Payable
On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable discussed in Note 9, “Debt and Convertible Notes Payable”, were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (10,582,821 shares of common stock on a post-Reverse Stock Split basis). The Contract Consideration Convertible Notes Payable converted into common stock shares, remeasured to a fair value of $40.6 million upon maturity, were recorded as additional paid-in-capital as of September 30, 2023.
On February 2, 2023, the Convertible Notes Payable pursuant to the PIPE transaction discussed in Note 9, “Debt and Convertible Notes Payable”, excluding those held by ProFrac Holdings, LLC, were converted on a pre-Reverse Stock Split basis, upon maturity, into 10,335,840 shares of common stock at a price of $0.8705 per share. The Convertible Notes Payable converted into common stock shares had a carrying value of $9.0 million, including accrued paid-in-kind interest of $0.8 million and were recorded as additional paid-in-capital upon conversion.
The Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants with an exercise price of $0.0001 per share and were recorded as additional paid-in-capital upon conversion. On September 6, 2023, the February 2023 Warrants issued upon the conversion of the Convertible Notes Payable held by ProFrac Holding, LLC were exercised and the Company issued, on a pre-Reverse Stock Split basis, 12,683,280 shares of the Company’s common stock (2,113,880 shares of the Company’s common stock on a post-Reverse Stock Split basis).
On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable discussed in Note 9, “Debt and Convertible Notes Payable”, remeasured to a fair value of $15.1 million upon maturity, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants and were recorded as additional paid-in-capital upon conversion. On September 6, 2023, the February 2023 Warrants issued upon the conversion of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were exercised and the Company issued on a pre-Reverse Stock Split basis, 12,683,281 shares of the Company’s common stock (2,113,881 shares of the Company’s common stock on a post-Reverse Stock Split basis).
Pre-Funded Warrants
On June 21, 2022, ProFrac Holdings II, LLC paid $19.5 million for Pre-Funded Warrants (the “June 2022 Warrants”) of the Company. The June 2022 Warrants were recorded in equity at their fair value of $11.1 million, estimated using a Black-Scholes Option Pricing model, less $1.2 million of transaction costs paid. The remaining cash received of $8.4 million was recognized as an equity contribution. The June 2022 Warrants permit ProFrac Holdings II, LLC to purchase on a pre-Reverse Stock Split basis 13,104,839 shares of common stock of the Company (2,184,140 shares of the Company’s common stock on a post-Reverse Stock Split basis) at an exercise price equal to $0.0001 per share, and a $4.5 million exercise fee. The June 2022 Warrants, net of transaction fees of $1.1 million, and the equity contribution of $8.4 million from ProFrac Holdings II, LLC were recorded as additional paid-in capital.
27

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The key inputs into the Black-Scholes Option Pricing Model used to estimate the fair value of the June 2022 Warrants as of the issuance on June 21, 2022 were as follows:

Risk-free interest rate | 3.21%
Expected volatility | 90.0%
Term until liquidation (years) | 2.00
Stock price (pre-Reverse Stock Split basis) | $1.11
Strike price (exercise fee) | $4.5 million

ProFrac Holdings II, LLC and its affiliates may not receive any voting or consent rights in respect of the June 2022 Warrants or the underlying shares of common stock unless and until (i) the Company has obtained approval from a majority of its shareholders excluding ProFrac Holdings II, LLC and its affiliates and (ii) ProFrac Holdings II, LLC has paid an additional $4.5 million to the Company; provided, however, that ProFrac Holdings II may exercise the June 2022 Warrants immediately prior to the sale of the shares of common stock subject to such exercise to a non-affiliate of ProFrac Holdings II. The additional $4.5 million will be accounted for as an equity contribution if received.
Note 14 — Earnings (Loss) Per Share
Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period, which includes the February 2023 Warrants (See Note 9, “Debt and Convertible Notes Payable”, and Note 13, “Stockholders’ Equity”). Diluted earnings (loss) per common share is calculated by dividing the adjusted net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive common share equivalents consist of incremental shares of common stock issuable upon conversion of convertible notes payable, exercise of stock warrants and vesting and settlement of stock awards. The dilutive effect of non-vested stock issued under share‑based compensation plans, shares issuable under the Employee Stock Purchase Plan (ESPP), employee stock options outstanding, and the Pre-Funded stock warrants are computed using the treasury stock method. The dilutive effect of the Convertible Notes is computed using the if‑converted method in accordance with ASU 2020-06, which was adopted by the Company on January 1, 2022.
28

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For all periods presented, weighted average shares and earnings (loss) per share reflect the effects of the Reverse Stock Split. The calculation of the basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2023 and 2022 is as follows (in thousands):

| Three months ended September 30, |  | Nine months ended September 30, |
| 2023 |  |  | 2022 |  | 2023 |  | 2022 |
Numerator: |  |  |  |  |  |  |  |  |
Net income (loss) for basic earnings per share | $ | 1,287 |  |  |  | $ | (18,794) |  |  | $ | 22,609 |  |  | $ | (23,278) |  |
Adjustments to net income available to shareholders |  |  |  |  |  |  |  |  |
Paid-in-Kind interest expense on convertible notes payable and Contract Consideration Convertible Notes Payable | — |  |  |  | — |  |  | 2,284 |  |  | — |  |
Valuation (gain)/loss on Contract Consideration Convertible Notes Payable carried at FV | — |  |  |  | — |  |  | (29,969) |  |  | — |  |
Adjusted net loss for diluted earnings per share | $ | 1,287 |  |  |  | $ | (18,794) |  |  | $ | (5,076) |  |  | $ | (23,278) |  |
Denominator: |  |  |  |  |  |  |  |  |
Basic weighted average shares outstanding | 29,358 |  |  |  | 12,552 |  |  | 23,291 |  |  | 12,349 |  |
Dilutive effect of convertible notes payable | — |  |  |  | — |  |  | 4,743 |  |  | — |  |
Dilutive effect of warrants outstanding | 1,238 |  |  |  | — |  |  | — |  |  | — |  |
Dilutive effect of stock options and restricted shares | 92 |  |  |  | — |  |  | — |  |  | — |  |
Diluted weighted average shares outstanding | 30,688 |  |  |  | 12,552 |  |  | 28,034 |  |  | 12,349 |  |
Basic earnings (loss) per share | $ | 0.04 |  |  |  | $ | (1.50) |  |  | $ | 0.97 |  |  | $ | (1.89) |  |
Diluted earnings (loss) per share | $ | 0.04 |  |  |  | $ | (1.50) |  |  | $ | (0.18) |  |  | $ | (1.89) |  |
Anti-dilutive incremental shares excluded from denominator for diluted earnings computation |
Average number of diluted shares for convertible notes payable (1) | — |  |  |  | 12,399 |  |  | — |  |  | 7,892 |  |
Average number of diluted shares for June 2022 stock warrants (1) | — |  |  |  | 1,483 |  |  | 1,308 |  |  | 554 |  |
Average number of diluted shares for options and restricted stock (1) | — |  |  |  | 113 |  |  | 111 |  |  | 110 |  |

(1) These items were not included in the dilution calculation for their respective periods due to their anti-dilutive effect as it would reduce the loss per share.
29

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 15 — Supplemental Cash Flow Information
Supplemental cash flow information is as follows (in thousands):

| Nine months ended September 30,
| 2023 |  | 2022
Supplemental cash flow information: |  |  |
Interest paid | $ | 36 |  |  | $ | 25 |
Supplemental non cash financing and investing activities: |  |  |
Conversion of convertible notes payable to common stock | 8,996 |  |  | 3,038 |
Conversion of convertible notes payable to February 2023 Warrants | 11,040 |  |  | — |
Conversion of Initial Contract Consideration Convertible Notes Payable to February 2023 Warrants | 15,092 |  |  | — |
Conversion of Amended Contract Consideration Convertible Notes Payable to common stock | 40,638 |  |  | — |
Issuance of convertible notes payable as consideration for ProFrac Agreements | — |  |  | 79,460 |

Note 16— Related Party Transactions
On February 2, 2022, the Company entered into the Initial ProFrac Agreement, upon issuance of $10 million in aggregate principal amount of the convertible notes (the “Contract Consideration Convertible Notes Payable”) to ProFrac Holdings LLC (see Note 9, “Debt and Convertible Notes Payable”). Under the Initial ProFrac Agreement, ProFrac Services, LLC is obligated to order chemicals from the Company at least equal to the greater of (a) the chemicals required for 33% of ProFrac Services, LLC’s hydraulic fracturing fleets and (b) a baseline measured by the first ten hydraulic fracturing fleets deployed by ProFrac Services, LLC during the term of the Initial ProFrac Agreement. If the minimum volumes are not achieved in any given year, ProFrac Services LLC shall pay to the Company, as liquidated damages an amount equal to twenty-five percent (25%) of the difference between (i) the aggregate purchase price of the quantity of products comprising the minimum purchase obligation and (ii) the actual purchased volume during such calendar year (“Contract Shortfall Fees”).
On May 17, 2022, the Company entered into the Amended ProFrac Agreement upon issuance of $50 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”). The Initial ProFrac Agreement was amended to (a) increase ProFrac Services LLC’s minimum purchase obligation for each year to the greater of 70% of ProFrac Services LLC’s requirements and a baseline measured by ProFrac Services, LLC’s first 30 hydraulic fracturing fleets, and (b) increase the term to 10 years.
On February 2, 2023, the Company entered into an amendment to the ProFrac Agreement (the “Amended ProFrac Agreement No. 2”). The Amended ProFrac Agreement No. 2 has an effective date of January 1, 2023. The ProFrac Agreement was amended to (1) provide a ramp-up period from January 1, 2023 to May 31, 2023 for ProFrac Services, LLC to increase the number of active hydraulic fracturing fleets to 30 fleets, (2) waive any Contract Shortfall Fee payment relating to any potential order shortfall prior to January 1, 2023, (3) add additional fees to certain products, and (4) provide margin increases based on margins with non-ProFrac customers.
The current measurement period for Contract Shortfall Fees is June 1, 2023 through December 31, 2023. The Company does not expect that the minimum purchase requirements will be met during the current measurement period, and as a result, the revenues for the three and nine months ended September 30, 2023 reflect expected Contract Shortfall Fee payments.
On February 2, 2023, the Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued paid-in-kind interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”) and subsequently exercised on September 6, 2023.
On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, with a carrying value of $11.0 million, including accrued interest of $1 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants and subsequently exercised on September 6, 2023 (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”). The fair value of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, as of February 2, 2023, was $15.1 million (see Note 10, “Fair Value Measurements”).
30

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable, with a carrying value of $55.3 million, including accrued interest of $5.3 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”). The fair value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable, as of May 17, 2023 was $40.6 million (see Note 10, “Fair Value Measurements”). As a result of the Reverse Stock Split, these shares were converted into 10,582,821 common shares.
During the three months ended September 30, 2023 and 2022, the Company’s revenues from ProFrac Services, LLC were $29.5 million and $30.4 million, respectively. During the nine months ended September 30, 2023 and 2022, the Company’s revenues from ProFrac Services LLC were $98.6 million and $48.1 million, respectively. For the three months ended September 30, 2023 and 2022, these revenues were net of amortization of contract assets of $1.3 million and $1.2 million. For the nine months ended September 30, 2023 and 2022, the revenues were net of amortization of contract assets of $3.7 million and $2.0 million, respectively. Cost of sales attributable to these revenues were $23.8 million and $31.6 million, respectively for the three months ended September 30, 2023 and 2022 and $88.6 million and $32.8 million for the nine months ended September 30, 2023 and 2022, respectively. As of September 30, 2023 and December 31, 2022 our accounts receivable from ProFrac Services, LLC was $24.8 million and $22.7 million, respectively which is recorded in accounts receivable, related party on the consolidated balance sheet.
Also, during 2023 and 2022, we had the following related party transactions with ProFrac Holdings, LLC and ProFrac Holdings II, LLC:
•PIPE Transaction (see Note 9, “Debt and Convertible Notes Payable”)
•June 2022 Warrants (see Note 13, “Stockholders’ Equity)
On March 21, 2022, the Convertible Notes Payable which had been purchased by certain funds associated with one of the Company’s directors including the D3 Family Fund and the D3 Bulldog Fund, which aggregated $3.0 million plus $39 thousand of accrued interest and amortization of issuance costs of $90 thousand, were converted on a pre-Reverse Stock Split basis into 2,793,030 shares of the Company’s common stock (465,505 common shares on a post-Reverse Stock Split basis).
Mr. Ted D. Brown was a Director of the Company beginning in November of 2013 and is the President and CEO of Confluence Resources LP (“Confluence”), a private oil and gas exploration and production company. The Company’s revenues and related cost of sales for product sold to Confluence were $1.4 million and $1.4 million, respectively, for the nine months ended September 30, 2022. As of June 9, 2022 Mr. Brown stepped down from being a Director of the Company and Confluence is no longer considered a related party as of June 9, 2022.
Note 17 — Business Segment, Geographic and Major Customer Information
Segment Information
Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the chief operating decision-maker in deciding how to allocate resources and assess performance. The operations of the Company are categorized into the following reportable segments:
Chemistry Technologies. The CT segment includes green specialty chemistries, logistics and technology services, which enable its customers to pursue improved efficiencies and performance throughout the life cycle of their wells, and also helping customers improve their ESG and operational goals. Customers of the CT segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies.
Data Analytics. The DA segment includes the design, development, production, sale and support of equipment and services that create and provide valuable information on the composition and properties of energy customers’ hydrocarbon fluids. The company markets products and services that support in-line data analysis of hydrocarbon components and properties. Customers of the DA segment span across the entire oil and gas market, from upstream production to midstream facilities to refineries and distribution networks.
Performance is based upon a variety of criteria. The primary financial measure is segment operating income (loss). Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segments.
31

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Summarized financial information of the reportable segments is as follows (in thousands):

As of and for the three months ended September 30, | Chemistry Technologies |  | Data Analytics |  | Corporate and Other |  | Total
2023 |  |  |  |  |  |  |
Revenue from external customers |  |  |  |  |  |  |
Products | $ | 15,764 |  |  | $ | 1,025 |  |  | $ | — |  |  | $ | 16,789 |
Services | 562 |  |  | 455 |  |  | — |  |  | 1,017 |
Total revenue from external customers | 16,326 |  |  | 1,480 |  |  | — |  |  | 17,806 |
Revenue from related party |  |  |  |  |  |  |
Products | 29,076 |  |  | — |  |  | — |  |  | 29,076 |
Services | 176 |  |  | 210 |  |  | — |  |  | 386 |
Total revenue from related parties | 29,252 |  |  | 210 |  |  | — |  |  | 29,462 |
Gross profit | 8,240 |  |  | 807 |  |  | — |  |  | 9,047 |
Income (loss) from operations | 5,519 |  |  | (37) |  |  | (3,863) |  |  | 1,619 |
Depreciation | 149 |  |  | 26 |  |  | 6 |  |  | 181 |
Additions to long-lived assets | — |  |  | 135 |  |  | — |  |  | 135 |
2022 |  |  |  |  |  |  |
Revenue from external customers |  |  |  |  |  |  |
Products | $ | 12,855 |  |  | $ | 1,302 |  |  | $ | — |  |  | $ | 14,157 |
Services | 656 |  |  | 393 |  |  | — |  |  | 1,049 |
Total revenue from external customers | 13,511 |  |  | 1,695 |  |  | — |  |  | 15,206 |
Revenue from related party |  |  |  |  |  |  |
Products | 30,417 |  |  | — |  |  | — |  |  | 30,417 |
Total revenue from related parties | 30,417 |  |  | — |  |  | — |  |  | 30,417 |
Gross profit (loss) | (2,406) |  |  | 564 |  |  | — |  |  | (1,842) |
Change in fair value of Contract Consideration Convertible Notes Payable | 4,250 |  |  | — |  |  | — |  |  | 4,250 |
Loss from operations | (10,603) |  |  | (745) |  |  | (4,931) |  |  | (16,279) |
Paid-in-kind interest on convertible notes payable | — |  |  | — |  |  | 483 |  |  | 483 |
Depreciation | 162 |  |  | 14 |  |  | 1 |  |  | 177 |
Additions to long-lived assets | 25 |  |  | 33 |  |  | 112 |  |  | 170 |

32

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

As of and for the nine months ended September 30, | Chemistry Technologies |  | Data Analytics |  | Corporate and Other |  | Total
2023 |  |  |  |  |  |  |
Revenue from external customers |  |  |  |  |  |  |
Products | $ | 39,150 |  |  | $ | 4,586 |  |  | $ | — |  |  | $ | 43,736 |
Services | 1,870 |  |  | 1,672 |  |  | — |  |  | 3,542 |
Total revenue from external customers | 41,020 |  |  | 6,258 |  |  | — |  |  | 47,278 |
Revenue from related party |  |  |  |  |  |  |
Products | 97,956 |  |  | 2 |  |  | — |  |  | 97,958 |
Services | 179 |  |  | 455 |  |  | — |  |  | 634 |
Total revenue from related parties | 98,135 |  |  | 457 |  |  | — |  |  | 98,592 |
Gross profit | 11,279 |  |  | 3,554 |  |  | — |  |  | 14,833 |
Change in fair value of Contract Consideration Convertible Notes Payable | (29,969) |  |  | — |  |  | — |  |  | (29,969) |
Income (loss) from operations | 32,694 |  |  | 550 |  |  | (12,440) |  |  | 20,804 |
Paid-in-kind interest on Contract Consideration Convertible Notes Payable | 2,129 |  |  | — |  |  | — |  |  | 2,129 |
Paid-in-kind interest on convertible notes payable | — |  |  | — |  |  | 155 |  |  | 155 |
Depreciation | 462 |  |  | 61 |  |  | 7 |  |  | 530 |
Additions to long-lived assets | 30 |  |  | 230 |  |  | 32 |  |  | 292 |
2022 |  |  |  |  |  |  |
Revenue from external customers |  |  |  |  |  |  |
Products | $ | 33,501 |  |  | $ | 2,393 |  |  | $ | — |  |  | $ | 35,894 |
Services | 1,432 |  |  | 1,086 |  |  | — |  |  | 2,518 |
Total revenue from external customers | 34,933 |  |  | 3,479 |  |  | — |  |  | 38,412 |
Revenue from related party |  |  |  |  |  |  |
Products | 49,462 |  |  | — |  |  | — |  |  | 49,462 |
Total revenue from related parties | 49,462 |  |  | — |  |  | — |  |  | 49,462 |
Gross profit (loss) | (4,637) |  |  | 11 |  |  | — |  |  | (4,626) |
Change in fair value of Contract Consideration Convertible Notes Payable | (9,016) |  |  | — |  |  | — |  |  | (9,016) |
Loss from operations | (1,716) |  |  | (2,751) |  |  | (14,057) |  |  | (18,524) |
Paid-in-kind interest on Contract Consideration Convertible Notes Payable | 2,586 |  |  | — |  |  | — |  |  | 2,586 |
Paid-in-kind interest on convertible notes payable | — |  |  | — |  |  | 1,276 |  |  | 1,276 |
Depreciation | 507 |  |  | 45 |  |  | 2 |  |  | 554 |
Additions to long-lived assets | 30 |  |  | 33 |  |  | 112 |  |  | 175 |

33

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Assets of the Company by reportable segments are as follows (in thousands):

| September 30, 2023 |  | December 31, 2022
Chemistry Technologies | $ | 134,489 |  |  | $ | 146,542 |
Data Analytics | 7,124 |  |  | 5,645 |
Corporate and Other | 10,903 |  |  | 12,623 |
Total assets | $ | 152,516 |  |  | $ | 164,810 |

Geographic Information
Revenue by country is based on the location where services are provided and products are sold. For the three and nine months ended September 30, 2023 and 2022 no individual countries other than the U.S. accounted for more than 10% of revenue. Revenue by geographic location is as follows (in thousands):

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
U.S. (1) | $ | 46,401 |  |  | $ | 42,670 |  |  | $ | 141,251 |  |  | $ | 78,959 |
Other countries | 867 |  |  | 2,953 |  |  | 4,619 |  |  | 8,915 |
Total revenue | $ | 47,268 |  |  | $ | 45,623 |  |  | $ | 145,870 |  |  | $ | 87,874 |

(1) Includes revenue from related party
Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements.
Major Customers
Revenue from major customers, as a percentage of consolidated revenue, is as follows (in thousands):

Three months ended September 30, |  | Revenue |  | % of Total Revenue |  |  |  |
2023 |  |  |  |  |  |  |  |
Customer A (Related Party) |  | $ | 29,462 |  |  | 62.3 | % |  |  |  |
2022 |  |  |  |  |  |  |  |
Customer A (Related Party) |  | $ | 30,417 |  |  | 66.7 | % |  |  |  |

Nine months ended September 30, |  | Revenue |  | % of Total Revenue |  |  |  |
2023 |  |  |  |  |  |  |  |
Customer A (Related Party) |  | $ | 98,592 |  |  | 67.6 | % |  |  |  |
2022 |  |  |  |  |  |  |  |
Customer A (Related Party) |  | $ | 48,074 |  |  | 54.7 | % |  |  |  |
Customer B |  | 10,905 |  |  | 12.4 | % |  |  |  |

The concentration with ProFrac Services, LLC and in the oil and gas industry increases credit, commodity and business risk.
34

FLOTEK INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Major Suppliers
Expenditure with major suppliers, as a percentage of consolidated supplier expenditure, is as follows (in thousands):

Three months ended September 30, |  | Expenditure |  | % of Total Expenditure |  |  |  |
2023 |  |  |  |  |  |  |  |
Supplier A |  | $ | 6,094 |  |  | 25.3 | % |  |  |  |
Supplier B |  | 5,581 |  |  | 23.2 | % |  |  |  |
Supplier C |  | 4,197 |  |  | 17.4 | % |  |  |  |
2022 |  |  |  |  |  |  |  |
Supplier A |  | $ | 10,882 |  |  | 32.7 | % |  |  |  |
Supplier B |  | 6,147 |  |  | 18.5 | % |  |  |  |
Supplier C |  | 5,552 |  |  | 16.7 | % |  |  |  |

Nine months ended September 30, |  | Expenditure |  | % of Total Expenditure |  |  |  |
2023 |  |  |  |  |  |  |  |
Supplier A |  | $ | 36,318 |  |  | 32.5 | % |  |  |  |
Supplier B |  | 21,752 |  |  | 19.5 | % |  |  |  |
Supplier C |  | 13,151 |  |  | 11.8 | % |  |  |  |
2022 |  |  |  |  |  |  |  |
Supplier A |  | $ | 18,505 |  |  | 28.5 | % |  |  |  |
Supplier B |  | 11,706 |  |  | 18.0 | % |  |  |  |
Supplier C |  | 8,826 |  |  | 13.6 | % |  |  |  |

Note 18 — Subsequent Events
We have evaluated the effects of events that have occurred subsequent to September 30, 2023, and there have been no material events that would require recognition in the September 30, 2023 interim financial statements or disclosure in the notes to the consolidated financial statements.
35

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Flotek,” the "Company," "we," "us" and "our" refer to Flotek Industries, Inc. and its wholly-owned subsidiaries.
The following discussion should be read in conjunction with the Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (“Annual Report” or “2022 Annual Report”) filed with the U.S. Securities and Exchange Commission (the “SEC”) and the unaudited consolidated financial statements and accompanying notes included herein. Comparative segment revenues and related financial information are discussed herein and are presented in Note 17 to our unaudited consolidated financial statements. See “Forward Looking Statements” in this report and “Risk Factors” included in our filings with the SEC, including our Quarterly Reports on Form 10-Q and our 2022 Annual Report, for a description of important factors that could cause actual results to differ from expected results. Our historical financial information may not be indicative of our future performance.
Executive Summary
Flotek creates unique solutions to reduce the environmental impact of energy on air, water, land and people. A technology-driven, specialty green chemistry and data technology company, Flotek helps customers across industrial and commercial markets improve their environmental performance. The Company serves specialty chemistry needs for both domestic and international energy markets.
The Company has two operating segments, Chemistry Technologies (“CT”) and Data Analytics (“DA”), which are both supported by the Company’s continuing Research and Innovation (“R&I”) advanced laboratory capabilities.
Company Overview
Chemistry Technologies
We believe that the Company’s CT segment provides sustainable, optimized chemistry solutions that maximize our customers’ value by elevating their environmental, social and governance (“ESG”) performance, lowering operational costs, and delivering improved return on invested capital. The Company’s proprietary green chemistries, specialty chemistries, logistics, and technology services enable its customers to pursue improved efficiencies and performance throughout the life cycle of its desired chemical applications program. The Company designs, develops, manufactures, packages, distributes and markets optimized chemistry solutions that accelerate existing sustainability practices to reduce the environmental impact of energy on the air, water, land and people.
Customers of the CT segment include those of energy related markets, such as our related party ProFrac Services, LLC, as well as consumer and industrial applications. Major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, geothermal energy companies, solar energy companies and advanced alternative energy companies benefit from our best-in-class technology, field operations, and continuous improvement exercises that go beyond existing sustainability practices.
Data Analytics
The DA segment delivers real-time information and insights to our customers to enable optimization of operations and reduction of emissions and their carbon intensity. Real-time composition and physical properties are delivered simultaneously on their refined fuels, natural gas liquids (“NGLs”), natural gas, crude oil, and condensates using the industry’s only field-deployable, in-line optical near-infra-red spectrometer that generates no emissions. The instrument's response is processed with advanced chemometrics modeling, artificial intelligence, and machine learning algorithms to deliver these valuable insights every 15 seconds.
We believe customers using this technology have obtained significant benefits, including additional profits, by enhancing operations in crude/condensates stabilization, blending operations, reduction of transmix, increasing efficiencies and optimization of gas plants, and ensuring product quality while reducing giveaways, i.e., providing higher value products at the lower value products prices. More efficient operations have the benefit of reducing their carbon footprint, e.g., less flaring and reduction in energy expenditure for compression and re-processing. Our customers in North America include the supermajors, some of the largest midstream companies and large gas processing plants. We have developed a line of Verax™ analyzers for deployment internationally which was certified for compliance in hazardous locations and harsh weather conditions.
36

Research & Innovation
R&I supports the acceleration of ESG solutions for both segments through green chemistry formulation, specialty chemical formulations, EPA regulatory guidance, technical support, basin and reservoir studies, data analytics and new technology projects. The purpose of R&I is to supply the Company’s segments with enhanced products and services that generate current and future revenues, while advising Company management on opportunities concerning technology, environmental and industry trends. The R&I facilities support advances in chemistry performance, detection, optimization and manufacturing.
Outlook
Our business is subject to numerous variables which impact our outlook and expectations given the shifting conditions of the industry and weather volatility. We have based our outlook on the market conditions we perceive today. Changes often occur.
Energy
We continue to believe we are experiencing a tight supply cycle for oil and gas triggered by an extended period of underinvestment in energy development, infrastructure and new sources of oil and gas production. The demand for oil and gas and related services fluctuates due to numerous factors including weather and macroeconomic and geopolitical conditions. While we have experienced some recent weakness in onshore drilling and completion activity, we believe that the fundamental outlook for the demand for oil and gas services remains strong. Independent exploration and production companies operate the majority of U.S. land rigs and react quickly to changing commodity prices. In the current commodity price environment, we expect these companies to maintain or increase activity and the larger companies to have modest spending increases over the next 12 months.
Digital Analytics
The use of data and digital analytics is a growing trend in all industries where technology is leveraged to analyze large datasets of operational information to improve performance, as well as for predictive maintenance, advanced safety measures and reduced environmental impact of operations. We believe Verax™ analyzers have gained a foothold in North American markets for critical applications where compositional information is needed in real-time. The technology delivers insight on valuable operations data like vapor pressure, boiling point, flash point, octane level, API (American Petroleum Institute) gravity, viscosity, BTU (British Thermal Unit) and more, simultaneously. We continue to collaborate with our customers to identify further facilities and applications where our technology has the highest value. To drive recurring revenue, we continue to build on the modular nature of our sensor and analysis packages with new data processing techniques that enhance the value of our installations. AIDA (Automated Interface Detection Algorithm) provides real-time detection of interfaces in a liquids pipeline without the need for additional sampling or chemometric modeling. The application can identify products such as refined fuels, crude and NGLs with its advanced machine learning algorithms and detect interfaces real-time versus traditional lab analysis. We believe this allows customers to cut batches quickly and accurately, reduce transmix and minimize off-spec product that requires downgrades. We are also gaining traction leveraging the Verax™ in applications where operators and service companies are using field gas as a substitute for diesel in dual fuel engines as the market moves to Tier 4 equipment and eFleets. Analyzing this in real-time allows companies to maximize the substitution rate while lowering emissions, reducing fuel consumption/costs, and protecting the equipment from damage.
ESG
ESG-focused solutions continue to be an emphasis for the Company as the energy, industrial and consumer markets are seeking to accelerate their focus on sustainability and minimized impact on the environment. We anticipate the Company’s products and services could offer a significant benefit to businesses seeking to improve their ESG performance, including improving safety, reliability and efficiency of their operations. The Company offers sustainable chemistry solutions, tailoring product selection to enable operational efficiencies, improve water management and reduce greenhouse gas emissions for its customers in the exploration and production sector of the oil and gas industry. Further, the Company’s patented line of Complex nano-Fluid® (also known as CnF®) products are formulated with highly effective, plant-based solvents offering safer, renewable and sustainable alternatives to toxic BTEX-based (benzene, toluene, ethylbenzene and xylene) chemicals. Additionally, we believe the Company’s real-time sensor technology helps to enable process and operational efficiencies, minimize waste and processing and reduce emissions.
We believe the industry focus on maintaining a “social license to operate” provides the platform to accelerate the sale of our products and services that we believe can help the customer achieve a greener goal. We believe the performance driven ESG focus of the Company assists in reducing environmental liabilities and improving returns for our customers.
37

Supply Chain
The principal supply issues facing our industry for the next twelve months will include:
•Fluctuating freight costs for shipping to our customers;
•Availability of raw materials;
•Labor shortages; and
•Demand forecasting.
All bidding will require the risk of shipping costs and delays to be factored into proposals. Trucking availability and pricing will impact North American opportunities while security of delivery for sea-freight could impact sales of North American manufactured goods being delivered internationally for the foreseeable future. The overall flow of materials globally could experience price increases. Accelerating tensions in the Middle East could also result in supply disruption.
New York Stock Exchange (“NYSE”) Continued Listing Requirements
The Company’s common stock is currently listed on the NYSE. On April 12, 2023, the Company received written notice from the NYSE that the average closing price of the Company’s shares of common stock was below $1.00 per share over a period of 30 consecutive days, which is below the requirement for continued listing on the NYSE. In accordance with applicable NYSE procedures, the Company notified the NYSE that it intended to cure the $1.00 per share deficiency.
On September 25, 2023, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company to effect a 1-for-6 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock. On October 2, 2023, as a result of the Reverse Stock Split, the Company received written notice from the NYSE that the Company had regained compliance with the NYSE’s continued listing criterion of a minimum share price of $1.00 per share over a 30-day trading period.
ProFrac Supply Agreement
On February 2, 2022, the Company entered into the Initial ProFrac Agreement, which was subsequently amended on May 17, 2022 and February 1, 2023 (collectively, the “ProFrac Agreement”).
The ProFrac Agreement contains minimum requirements for chemistry purchases. If the minimum volumes are not achieved within the applicable measurement period, ProFrac Services LLC is required to pay to the Company, as liquidated damages, an amount equal to twenty-five percent (25%) of the difference between (i) the aggregate purchase price of the quantity of products comprising the minimum purchase obligation and (ii) the actual purchased volume during the measurement period (“Contract Shortfall Fees”). The current measurement period for Contract Shortfall Fees is June 1, 2023 through December 31, 2023. The Company does not expect that the minimum purchase requirements will be met during the current measurement period, and as a result, the revenues for the three and nine months ended September 30, 2023 reflect expected Contract Shortfall Fees payments.
38

Consolidated Results of Operations (in thousands)

| Three months ended September 30, |  |  |  |  | Nine months ended September 30,
| 2023 |  | 2022 |  |  |  |  | 2023 |  | 2022
Revenue |  |  |  |  |  |  |  |  |  |
Revenue from external customers | $ | 17,806 |  |  | $ | 15,206 |  |  |  |  |  | $ | 47,278 |  |  | $ | 38,412 |
Revenue from related party | 29,462 |  |  | 30,417 |  |  |  |  |  | 98,592 |  |  | 49,462 |
Total revenues | 47,268 |  |  | 45,623 |  |  |  |  |  | 145,870 |  |  | 87,874 |
Cost of sales | 38,221 |  |  | 47,465 |  |  |  |  |  | 131,037 |  |  | 92,500 |
Cost of sales % | 80.9 | % |  | 104.0 | % |  |  |  |  | 89.8 | % |  | 105.3 | %
Gross profit (loss) | 9,047 |  |  | (1,842) |  |  |  |  |  | 14,833 |  |  | (4,626) |
Gross profit (loss) % | 19.1 | % |  | (4.0) | % |  |  |  |  | 10.2 | % |  | (5.3) | %
Selling general and administrative | 6,526 |  |  | 9,254 |  |  |  |  |  | 21,303 |  |  | 20,958 |
Selling general and administrative % | 13.8 | % |  | 20.3 | % |  |  |  |  | 14.6 | % |  | 23.9 | %
Depreciation | 181 |  |  | 177 |  |  |  |  |  | 530 |  |  | 554 |
Research and development | 757 |  |  | 985 |  |  |  |  |  | 2,231 |  |  | 3,515 |
Severance costs | 2 |  |  | (219) |  |  |  |  |  | (28) |  |  | 387 |
Gain on sale of property and equipment | (38) |  |  | (10) |  |  |  |  |  | (38) |  |  | (1,916) |
Gain on lease termination | — |  |  | — |  |  |  |  |  | — |  |  | (584) |
Loss (gain) in fair value of Contract Consideration Convertible Notes Payable | — |  |  | 4,250 |  |  |  |  |  | (29,969) |  |  | (9,016) |
Income (loss) from operations | 1,619 |  |  | (16,279) |  |  |  |  |  | 20,804 |  |  | (18,524) |
Operating margin % | 3.4 | % |  | (35.7) | % |  |  |  |  | 14.3 | % |  | (21.1) | %
Interest and other income (expense), net | (251) |  |  | (2,508) |  |  |  |  |  | 1,903 |  |  | (4,653) |
Income (loss) before income taxes | 1,368 |  |  | (18,787) |  |  |  |  |  | 22,707 |  |  | (23,177) |
Income tax (expense) benefit | (81) |  |  | (7) |  |  |  |  |  | (98) |  |  | (101) |
Net income (loss) | $ | 1,287 |  |  | $ | (18,794) |  |  |  |  |  | $ | 22,609 |  |  | $ | (23,278) |
Net income (loss) % | 2.7 | % |  | (41.2) | % |  |  |  |  | 15.5 | % |  | (26.5) | %

Consolidated revenue for the three months ended September 30, 2023 increased $1.6 million, or 4%, versus the same period of 2022, driven by increased revenue from external customers. Related party revenues declined by 3% from the third quarter of 2022 as a result of reduced activity under the ProFrac Agreement. The reduced ProFrac revenues were partially offset by accrued Contract Shortfall Fees. Related party revenues in the CT segment are net of $1.3 million and $1.2 million of contract assets amortization for the three months ended September 30, 2023 and 2022, respectively.
Consolidated revenue for the nine months ended September 30, 2023 increased $58.0 million, or 66%, versus the same period of 2022, driven by higher related party activity under the ProFrac Agreement, which commenced during the second quarter of 2022, accrued Contract Shortfall Fees and increased revenue from external customers. Related party revenues in the CT segment are net of $3.7 million and $2.0 million of contract assets amortization for the nine months ended September 30, 2023 and 2022, respectively.
Consolidated cost of sales for the three and nine months ended September 30, 2023 decreased $9.2 million, or 19%, and increased $38.5 million, or 42%, respectively, versus the same periods of 2022, primarily due to decreased product sales partially offset by increased tank rental and maintenance costs. Consolidated cost of sales percentage improved 23% and 15% in the three and nine months ended September 30, 2023 as a result of our higher revenue volumes, accrued Contract Shortfall Fees and cost management.
SG&A expenses for the three months ended September 30, 2023 decreased $2.7 million, or 29%, versus the same period of 2022. The decrease relates to decreased personnel costs, professional fees and stock compensation costs. SG&A expenses for the nine months ended September 30, 2023 increased $0.3 million, or 2%, versus the same period of 2022.
Research and development (“R&D”) costs for the three and nine months ended September 30, 2023 decreased $0.2 million, or 23%, and decreased $1.3 million, or 37%, respectively, versus the same periods of 2022 due to lower personnel cost driven by headcount optimization.
39

Income from operations increased $17.9 million for the three months ended September 30, 2023, versus the same period in 2022. The increase is primarily driven by a $9.2 million decrease in consolidated cost of sales, the loss in fair value of the Contract Consideration Convertible Notes Payable of $4.3 million for the three months ended September 30, 2022 with no corresponding fair value change in 2023, accrued Contract Shortfall Fees and decreased SG&A costs for the three months ended September 30, 2023 of $2.7 million. Income from operations increased $39.3 million for the nine months ended September 30, 2023, versus the same period of 2022. The improvement is primarily driven by an increase in the gain in fair value of the Contract Consideration Convertible Notes Payable of $21.0 million compared to the same period of 2022, an increase in gross profit of $19.5 million driven by increased related party and external customer revenue, including accrued Contract Shortfall Fees, and a $1.3 million decrease in research and development costs. The improvement is partially offset by an increase in SG&A costs of $0.3 million and a decrease in gains on the sale of assets and lease termination of $1.9 million and $0.6 million, respectively, reported in the nine months ended September 30, 2022.
Interest and other expense for the three months ended September 30, 2023 decreased $2.3 million, or 90%, driven by a reduction in interest expense as a result of the Convertible Notes Payable and the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable maturing in the first quarter of 2023 and the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable maturing in the second quarter of 2023 (see Note 9, “Debt and Convertible Notes Payable”). Interest and other income for the nine months ended September 30, 2023 increased $6.6 million, or 141%, driven primarily by a $4.5 million gain for the forgiveness of the Flotek PPP loan (see Note 9, “Debt and Convertible Notes Payable”) and a $2.0 million decrease in interest expense related to the Convertible Notes Payable.
The Company’s income tax expense for the three and nine months ended September 30, 2023 and 2022 was minimal.
Results by Segment (in thousands):
Chemistry Technologies Results of Operations:

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Revenue from external customers | $ | 16,326 |  |  | $ | 13,511 |  |  | $ | 41,020 |  |  | $ | 34,933 |
Revenue from related party | 29,252 |  |  | 30,417 |  |  | 98,135 |  |  | 49,462 |
Income (loss) from operations | 5,519 |  |  | (10,603) |  |  | 32,694 |  |  | (1,716) |

CT revenue from external customers for the three months ended September 30, 2023 increased $2.8 million, or 21%, compared to the same period of 2022 driven mainly by expansion of customer base. Revenue from related parties decreased $1.2 million, or 4%, compared to the same period of 2022. The decreased revenue in 2023 is driven by reduced activity under the ProFrac Agreement which was partially offset by accrued Contract Shortfall Fees.
CT revenue from external customers for the nine months ended September 30, 2023 increased $6.1 million, or 17%, compared to the same period of 2022 driven mainly by activity with new customers partially offset by decreased international activity. Revenue from related parties for the nine months ended September 30, 2023 increased $48.7 million, or 98%, compared to the same period of 2022. The increased revenue in 2023 is driven by increased activity and accrued Contract Shortfall Fees under the ProFrac Agreement, which commenced in the second quarter of 2022.
Income from operations for the CT segment for the three months ended September 30, 2023 increased $16.1 million compared to the same period of 2022. The increase is primarily due to increased gross profit of $10.6 million attributable to increased activity and accrued Contract Shortfall Fees. Additionally, the increase is attributable to a decrease in the loss in fair value of the Contract Consideration Convertible Notes Payable of $4.3 million for the three months ended September 30, 2023 compared to the same period of 2022.
Income from operations for the CT segment for the nine months ended September 30, 2023 increased $34.4 million compared to the same period of 2022. The improvement is primarily attributable to the gain in fair value of the Contract Consideration Convertible Notes Payable of $30.0 million for the nine months ended September 30, 2023 compared to $9.0 million for the same period of 2022 and an increase in gross profit of $15.9 million attributable to increased activity and accrued Contract Shortfall Fees. During the nine months ended September 30, 2022, income from operations included gains on sale of assets and lease termination of $1.9 million and $0.6 million, respectively.
40

Data Analytics Results of Operations:

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Revenue from external customers | $ | 1,480 |  |  | $ | 1,695 |  |  | $ | 6,258 |  |  | $ | 3,479 |
Revenue from related party | 210 |  |  | — |  |  | 457 |  |  | — |
Income (loss) from operations | (37) |  |  | (745) |  |  | 550 |  |  | (2,751) |

DA revenue from external customers for the three months ended September 30, 2023 decreased $0.2 million, or 13%, compared to the same period of 2022 driven by reduced volumes with various customers. Revenue from related party customers for the three months ended September 30, 2023 was $0.2 million relating to services provided to ProFrac.
DA revenue from external customers for the nine months ended September 30, 2023 increased $2.8 million, or 80%, compared to the same period of 2022 primarily due to significant products revenues from increased unit sales. Revenue from related party customers for the nine months ended September 30, 2023 was $0.5 million relating to services provided to ProFrac.
Income from operations for the DA segment for the three months ended September 30, 2023 increased $0.7 million, or 95%, compared to the same period for 2022 driven primarily by increased activity and lower personnel costs and R&D expense. Income from operations for the DA segment for the nine months ended September 30, 2023 increased $3.3 million compared to the same period for 2022 primarily driven by increased activity and decreased R&D expense and personnel costs.
Corporate and Other Results of Operations:

| Three months ended September 30, |  | Nine months ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Loss from operations | $ | (3,863) |  |  | $ | (4,931) |  |  | $ | (12,440) |  |  | $ | (14,057) |

Loss from operations for the three months ended September 30, 2023 decreased $1.1 million, or 22%, compared to the same period of 2022 attributable to decreased salaries and bonus expense, decreased professional fees and decreased stock compensation expense. Loss from operations for the nine months ended September 30, 2023 decreased $1.6 million, or 12%, compared to the same period of 2022 attributable to decreased salaries and benefits from reduced headcount, lower stock compensation costs and reduced severance costs.
Capital Resources and Liquidity
Overview
The Company’s ongoing capital requirements relate to the acquisition and maintenance of equipment and funding working capital requirements. During the nine months ended September 30, 2023, the Company funded working capital requirements with cash on hand and borrowings under the ABL (as defined below) entered into in August 2023.
As of September 30, 2023, the Company had unrestricted cash and cash equivalents of $4.5 million compared to $12.3 million on December 31, 2022. In addition, at November 6, 2023, the Company had $6.4 million in available borrowings under its ABL. During the nine months ended September 30, 2023, the Company had operating income of $20.8 million, $9.2 million of cash used by operating activities, $0.5 million of cash used in investing activities and $1.9 million of cash provided by financing activities.
Asset Based Loan
On August 14, 2023, the Company entered into a 24-month revolving loan and security agreement in connection with an Asset Based Loan (the “ABL”). The ABL provides up to $10 million of initial credit availability, which is limited by a borrowing base consisting of:
•85% of eligible accounts receivable, plus
•60% of the value of eligible inventory not to exceed 100% of the eligible accounts receivable.
41

Under the initial terms of the ABL, the maximum credit availability could be increased based on the lesser of (i) 50% of the appraised value of real estate collateral held by the Company and (ii) $5 million. On October 5, 2023, the ABL was amended to increase its maximum borrowing base from $10.0 million to $13.8 million (the “Amended ABL”) subsequent to the appraisal of the real estate.
As of September 30, 2023, the Company had $3.4 million outstanding under the ABL. During the three and nine months ended September 30, 2023, the Company paid $0.2 million in interest and fees related to the ABL, which included the annual fee of $0.1 million. As of September 30, 2023, the Company had incurred origination costs of $0.5 million that was recorded as deferred financing costs to be amortized over the term of the ABL.
Borrowings under the ABL bear interest at the Wall Street Journal Prime Rate (subject to a floor of 5.50%) plus 2.5% per annum. The interest rate under the ABL was 11.0% as of September 30, 2023. The ABL contains an annual commitment fee equal to 1.0% of the ABL’s borrowing base. Additionally, the Company will be assessed a non-usage fee of 0.25% per quarter based on the difference between the average daily outstanding balance and the borrowing base limit of the ABL. If the ABL is terminated prior to the end of its 24-month term, the Company is required to pay an early termination fee of 2.50% of the borrowing base limit of the ABL (if terminated with more than 12 months remaining until the maturity date) or 1.50% of the borrowing base limit of the ABL (if terminated with less than 12 months remaining until the maturity date).
The ABL contains customary representations, warranties, covenants and events of default, the occurrence of which would permit the lender to accelerate the payment of any amounts borrowed. The ABL requires the Company to maintain a minimum Tangible Net Worth (as defined in the ABL) of not less than $11 million. In addition, the ABL provides the lender a blanket security interest on all or substantially all of the Company’s assets. The Company was in compliance with all of the covenants under the ABL as of September 30, 2023.
Going Concern
These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company’s ability to continue as a going concern exists.
The Company currently funds its operations with cash on hand, availability under the ABL (see Note 9, “Debt and Convertible Notes Payable”) and other current assets. While the Company generated $21.3 million of net income in the nine months ended September 30, 2023, the Company has a recent history of losses and negative cash flows from operations and expects to utilize a significant amount of cash within one year after the date of filing the unaudited condensed consolidated financial statements. The availability of capital is dependent on the Company’s operating cash flow currently expected to be principally derived from the ProFrac Agreement (see Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions”). It is not certain that the Company’s cash, availability under the ABL and other current assets, along with the Company’s forecasted cash flows from operations, will provide the Company with sufficient financial resources to fund operations and meet the Company’s capital requirements and anticipated obligations as they become due in the next twelve months. The Company may require additional liquidity to continue its operations over the next twelve months to sufficiently alleviate or mitigate the conditions and events noted above, which results in substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are filed.
During the third quarter of 2023, the Company entered into the ABL providing up to $10 million of initial credit availability, which is limited by a borrowing base. In October 2023, the maximum credit availability under the ABL was increased by $3.8 million. However, the Company may be unable to access further equity or debt financing if needed. As such, there can be no assurance that the Company will be able to obtain additional liquidity when needed or under acceptable terms, if at all.
The unaudited condensed consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern.
42

Cash Flows
Consolidated cash flows by type of activity are noted below (in thousands):

| Nine months ended September 30,
| 2023 |  | 2022
Net cash used in operating activities | $ | (9,248) |  |  | $ | (47,166) |
Net cash (used in) provided by investing activities | (525) |  |  | 4,040 |
Net cash provided by financing activities | 1,925 |  |  | 38,199 |
Effect of changes in exchange rates on cash and cash equivalents | 13 |  |  | 211 |
Net change in cash and cash equivalents and restricted cash | $ | (7,835) |  |  | $ | (4,716) |

Operating Activities
Net cash used in operating activities was $9.2 million during the nine months ended September 30, 2023 compared to $47.2 million for the same period of 2022. Consolidated net income for the nine months ended September 30, 2023 was $22.6 million compared to a net loss of $23.3 million for the nine months ended September 30, 2022.
During the nine months ended September 30, 2023, non-cash adjustments to net income totaled $25.8 million as compared to $0.3 million for the same period of 2022.
•For the nine months ended September 30, 2023 non-cash adjustments included $30.0 million for the change in fair value of Contract Consideration Convertible Notes Payable and $4.5 million for PPP loan forgiveness. These were offset by non-cash positive adjustments of $2.3 million paid-in-kind interest expense, $3.7 million amortization of contract assets and $2.3 million non-cash lease expense.
•For the nine months ended September 30, 2022 non-cash adjustments included $9.0 million for the change in fair value of Contract Consideration Convertible Notes Payable, $1.9 million gain on sale of property and equipment and $0.6 million gain on lease termination. These were offset by $3.9 million paid-in-kind interest expense and $2.3 million stock compensation expense.
During the nine months ended September 30, 2023, changes in working capital used $6.1 million of cash as compared to $23.6 million for the same period of 2022.
•For the nine months ended September 30, 2023 changes in working capital resulted primarily from a decrease in related party accounts receivable of $2.1 million, net inventories of $0.8 million and other assets of $0.9 million along with decreased accrued liabilities and operating lease liabilities of $3.2 million and $2.6 million, respectively partially offset by increases in third party accounts receivable of $3.5 million.
•For the nine months ended September 30, 2022, changes in working capital resulted primarily from an increase in accounts receivable and inventories of $30.4 million and $11.4 million, respectively, due to increased revenue, change in contract asset of $3.6 million attributable to fees associated with the Contract Consideration Convertible Notes Payable, and decreased accrued liabilities partially due to payment of a legal settlement accrued in 2021. This is partially offset by an increase in accounts payable of $22.0 million relating mainly to purchases made to support activity under the ProFrac Agreement.
Investing Activities
Net cash used in investing activities for the nine months ended September 30, 2023 was $0.5 million driven by capital expenditures. Net cash provided by investing activities for the nine months ended September 30, 2022 was $4.0 million from the sale of the manufacturing facility in Waller, Texas, which closed in April 2022.
Financing Activities
Net cash provided by financing activities for the nine months ended September 30, 2023 was $1.9 million and relates primarily to $3.4 million in net proceeds from the ABL partially offset by payments for forfeited stock options, ABL origination costs and payments to tax authorities for shares withheld from employees. Net cash provided by financing activities was $38.2 million for the nine months ended September 30, 2022, and relates primarily to the proceeds from the issuance of convertible notes and warrants partially offset by issuance costs.
43

Critical Accounting Policies and Estimates
The preparation of financial statements and related disclosures in conformity with U.S. GAAP and the Company’s discussion and analysis of its financial condition and operating results require the Company’s management to make judgments, assumptions, and estimates that affect the amounts reported. Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of the Company’s 2022 Annual Report describes the critical accounting policies and estimates used in the preparation of the Company’s condensed consolidated financial statements. Note 2, “Summary of Significant Accounting Policies”, of the Notes to Unaudited Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q and in the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2022 Annual Report describe the significant accounting policies and methods used in the preparation of the Company’s condensed consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
The Company is exposed to market risk from changes in interest rates, commodity prices and foreign currency exchange rates. There have been no material changes to the quantitative or qualitative disclosures about market risk set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” of the Company’s Annual Report.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. The Company’s disclosure controls and procedures are also designed to ensure such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance that control objectives are attained.
In accordance with Exchange Act Rules 13a–15(e) and 15d–15(e), we carried out an evaluation under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of September 30, 2023. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2023, our disclosure controls and procedures were not effective because of a material weakness in our internal control over financial reporting described below.
Material Weakness in Internal Control over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act, as amended.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
In connection with the preparation of the Company’s 2022 Annual Report, we conducted an evaluation to assess the effectiveness of our internal control over financial reporting as of December 31, 2022, and identified the material weakness described below that continues to exist as of September 30, 2023.
Specifically, (i) the Company did not have sufficient resources in place throughout the reporting period with the appropriate training and knowledge of internal controls over financial reporting in order to establish the Company’s financial reporting processes to design, implement and operate an effective system of internal control over financial reporting; (ii) the Company did not conduct an adequate continuous risk assessment over financial reporting to identify and analyze risks of financial misstatement due to error and/or fraud and to identify and assess necessary changes in financial reporting processes and internal controls impacted by significant changes in the business and increase in transactions; and (iii) the Company did not have an effective information and communication process that ensured appropriate and accurate information was available to financial reporting personnel on a timely basis in order that they could fulfill their roles and responsibilities.
44

Accordingly, the Company did not establish appropriate control activities through policies and procedures to mitigate risk to the achievement of the Company’s financial reporting objectives, as follows:
•The Company did not design effective controls over the identification and subsequent accounting for modifications to lease agreements;
•The Company did not design effective controls over the accuracy of prepaid asset accounts;
•The Company did not design effective controls over the completeness and accuracy of the related party revenue accrual at period end to ensure all sales are properly accounted for.
These control deficiencies resulted in several material and immaterial misstatements that were corrected prior to the issuance of the consolidated financial statements included in the 2022 Annual Report.
The Company believes that, notwithstanding the material weakness mentioned above, the unaudited condensed consolidated financial statements contained in this Form 10-Q fairly present, in all material respects, the financial condition, results of operations and cash flows of the Company in conformity with generally accepted accounting principles in the United States as of the dates and for the periods presented in this Form 10-Q.
Remediation Plan and Status
The Company has implemented and continues to implement certain remediation actions, and continues to evaluate the elements of the remediation plan. These elements include:
•Implementing a revised FY2023 financial control risk assessment process based on changes in process that have impacted the Company as well as a regularly recurring assessment process focused on identifying and analyzing risks of financial misstatements due to changes in our business or the nature of transactions; and
•Enhancing the information and communication processes to ensure the organization communicates information internally in a timely manner, including information regarding objectives, responsibilities and the functioning of internal controls over financial reporting. Changes will include more frequent discussion of significant business transactions and the impact of these transactions on the Company’s financial reporting, and improving communication to employees regarding their responsibilities for ensuring that effective internal controls are maintained.
The Company believes that the actions listed above will provide appropriate remediation of the material weakness; however, the testing of the effectiveness of the controls remains ongoing by the Company. Due to the nature of the remediation process and the need for sufficient time after implementation to evaluate and test the design and effectiveness of the controls, no assurance can be given as to the timing for completion of remediation. The material weakness will be considered fully remediated when the Company concludes that the controls have been operating for a sufficient amount of time and the design and effectiveness of the controls are validated by management.
Changes in Internal Controls over Financial Reporting
Except as described above in “Remediation Plan and Status”, there have been no changes in the Company’s system of internal control over financial reporting (identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) under the Exchange Act) during the three months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
45

PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Except as described in Note 12, “Commitments and Contingencies” of the Notes to Unaudited Condensed Consolidated Financial Statements contained in Part I, Item 1, there have been no material changes in the legal proceedings as described in “Item3. - Legal Proceedings” in the Company’s Annual Report on Form 10-K filed with the SEC on March 23, 2023.
Item 1A. Risk Factors
In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors contained in “Item 1A.-Risk Factors” in our 2022 Annual Report, which could materially affect our business, financial condition and/or future results. As of September 30, 2023, there have been no material changes in our risk factors from those set forth in the Annual Report. The risks described in the Annual Report are not the only risks facing our company. Additional risks and uncertainties not currently known to us or those we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or future results.
Item 2. Unregistered Sales of Equity Securities
Unregistered Sales of Equity Securities
None
Issuer Repurchases of Equity Securities
The Company’s stock compensation plans allow employees to elect to have shares withheld to satisfy their tax liabilities related to non-qualified stock options exercised or restricted stock vested or to pay the exercise price of the options. When this settlement method is elected by the employee, the Company repurchases the shares withheld upon vesting or exercise of the award. Repurchases of the Company’s equity securities during the three months ended September 30, 2023 that the Company made or were made on behalf of the Company or any “affiliated purchaser,” as defined in Rule 10b-18(a)(3) under the Exchange Act are as follows:

Period | Total Number of Shares Purchased (1)(2) |  | Average Price Paid per Share(2) |  |  |  |
July 1, 2023 to July 31, 2023 | 247 |  |  | $ | 4.95 |  |  |  |  |
August 1, 2023 to August 31, 2023 | 3,247 |  |  | $ | 4.74 |  |  |  |  |
September 1, 2023 to September 30, 2023 | — |  |  | $ | — |  |  |  |  |
Total | 3,494 |  |  |  |  |  |  |

(1) The Company purchases shares of its common stock (a) to satisfy tax withholding requirements and payment remittance obligations related to period vesting of restricted shares and exercise of non-qualified stock options and (b) to satisfy payments required for common stock upon the exercise of stock options.
(2) The total number of shares purchased and average price paid per share reflect the effects of the Reverse Stock Split.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Effective November 6, 2023, the Company’s Board of Directors approved and adopted certain amendments to the Second Amended and Restated Bylaws of the Company (as amended, the “Bylaws”), to clarify that the Chairman of the Board is not an officer of the Company. The foregoing description of the amendments does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws, a copy of which is filed as Exhibit 3.6 hereto and is incorporated herein by reference.
46

Item 6. Exhibit

Exhibit Number |  | Description of Exhibit
2.1 | *** | Membership Interest Purchase Agreement, dated as of May 18, 2020, by and between the Company, JP3 Measurement, LLC, the Sellers party thereto, and John A. Cardwell, as Seller Representative) (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on May 19, 2020).
3.1 |  | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q for the quarter ended September 30, 2007).
3.2 |  | Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q for the quarter ended September 30, 2009).
3.3 |  | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Flotek Industries, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on May 7, 2020).
3.4 |  | Certificate of Amendment to the Amended and Restated Certificate of Incorporation (form of which is incorporated by reference to Appendix B to the Company’s Proxy Statement filed on April 5, 2022).
3.5 |  | Certificate of Amendment to Amended and Restated Certificate of Incorporation of Flotek Industries, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on September 25, 2023).
3.6 | * | Second Amended and Restated Bylaws, as amended
4.1 |  | Form of Certificate of Common Stock (incorporated by reference to Appendix E to the Company’s Definitive Proxy Statement filed on September 27, 2001).
4.2 |  | Form of Convertible Note (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on February 4, 2022).
4.3 |  | Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Form 8-K filed on February 4, 2022).
4.4 |  | 10% Convertible PIK Note dated May 17, 2022 (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed on May 18, 2022).
4.5 |  | Form of Pre-Funded Warrants (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on June 23, 2022).
10.1 |  | Revolving Loan and Security Agreement dated as of August 14, 2023, among Flotek Industries, Inc., Flotek Chemistry, LLC and JP3 Measurement, LLC, as borrowers, and Amerisource Funding, Inc., as lender (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on August 14, 2023).
31.1 | * | Rule 13a-14(a) Certification of Principal Executive Officer.
31.2 | * | Rule 13a-14(a) Certification of Principal Financial Officer.
32.1 | ** | Section 1350 Certification of Principal Executive Officer.
32.2 | ** | Section 1350 Certification of Principal Financial Officer.
101.INS | * | Inline XBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document
101.SCH | * | Inline XBRL Schema Document
101.CAL | * | Inline XBRL Calculation Linkbase Document
101.LAB | * | Inline XBRL Label Linkbase Document
101.PRE | * | Inline XBRL Presentation Linkbase Document
101.DEF | * | Inline XBRL Definition Linkbase Document
104 | * | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* |  | Filed with this Form 10-Q.
** |  | Furnished with this Form 10-Q, not filed.
*** |  | Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission or its staff.

47

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 8, 2023

FLOTEK INDUSTRIES, INC.
By: |  | /s/ Ryan Ezell
|  | Ryan Ezell
|  | Chief Executive Officer
By: |  | /s/ Bond Clement
|  | Bond Clement
|  | Chief Financial Officer (Principal Financial and Accounting Officer)

48